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Cab-eticulin, (397) 245 
Calystegia sepum. (397) 352 
CAMP. (378) 27; (382) 89: (383) 63; (391) 263: (395) 241,272; (396) 
271: (397) 89 
CAMP analog, (396) 309 
CAMP responsive element, (385) 34 
cAMP-dependent protein kinase, (379) 299; (382) 53,93; (384) 138 
CAMP-phosphodiesterase. (384) 97 
Camptothecin and analogs, (396) 289 
Cancer. (380) 103: (385) 233: (394) 129; (399) 158 
Candida, (381) 195 
Cannabinoid receptor. (393) 231 
Cannabis. (393) 23 1 
Cap structure, (394) 233 
Cap Z. (37X) 258 
CAPIR, (398) 74 
Capacitation, (396) 227 
Capacitative calcium influx. (386) 39; (394) 159 
CAPAN. (393) 264 
Capillary. (394) 335 
Capillary electrophoresis, (382) 73; (397) 45 
Capping protein, (378) 258 
Cansicum annuum. (394) 2 I 
Capsular polysaccharide. (391) 157 
Carbamoylphosphate synthetase, (399) 3 IO 
Carbohydrate antigen, (395) 68 
Carbohydrate binding residue, (390) 271 
Carbohydrate-binding site, (389) 289 
Carbon dioxide, (399) 67 
Carbon monoxide, (383) I3 
Carbon source starvation, (390) 3 I9 
Carbon starvation. (383) 175 
Carbonic anhydrase-related protein, (398) 322 
2Carboxyarabinitol l-phosphate. (38X) 223 
y-Carboxvlation. (385) 241 
Carboxymethylation, (397) 122 
Carboxypeptidase, (384) 31 
Carcinus mamas, (384) 251 
Cardiac hypertrophy, (379) 255 
a-Cardiac MHC, (391) 39 
Cardiac muscle, (395) 148 
Cardiac myocyte, (383) 267: (389) 167; (393) 174 
Cardiac troponin, (384) 43 
Cardiolipin, (389) 28 I: (397) 260 
Cardiomyocyte, (395) 148 
Carnitine. (390) 1; (399) 3 IO 
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Carnitine palmitoyl transferase, (390) 1 
Carnitine translocase. (397) 260 
Carotene, (384) 240 
Carotenoid, (389) 199 
Carrier regulation. (395) 272 
Carrier system. (390) 3 I5 
Carrot cell, (380) 97 
Carryover orevention. (388) 1 
Cartilage, (393) 307 
Cartilage degradation, (380) I7 
Casein kinase. (382) 149 
Casein kinase II, (378) 115; (391) 238: (398) 317 
Casein kinase II activity. (398) 317 
CAT assay. (397) 207 
CAT, chloramphenicol acetyltransferase. (380) 204 
Catabolite repression. (390) 3 19 
Catalase, (382) 28 1 
Catalase gene, (383) I50 
Catalysis, (381) 106; (383) 259 
Catalytic antibody, (395) 73 
Catalytic domain, (398) 31 
Catalytic mechanism, (382) 186 
Catalytic site, (390) 339 
Cataract, (395) 174 
Catechol. (384) 25 I 
Catecholamine, (399) 9 
Cathelin, (390) 95; (391) 5 
Cathepsin. (389) 55; (391) 109; (392) 233: (393) 307: (395) I13 
Cathepsin B. (384) ?I 1: (391) 297: (394) 307 
Cathepsin C, (392) 277 
Cathepsin D. (382) 37; (396) 139; (397) 313 
Cathepsin G. (386) 82 
Cathepsin L, (394) 345 
Cation dependence, (389) I79 
Cation transport. (395) 153 
Cationic cholesterol, (397) 207 
Cationic lipid. (391) 215 
Cationic liposome, (380) 108: (397) 207 
Caveolae, (380) 198: (388) 143: (389) 52 
c,hb3-type cytochrome c oxidase, (394) 349 
CBFI. (387) 179 
CBF3, (389) 70 
Cbl. Fey receptor, (382) I I 
C-cell, (393) 248 
CCTn-chaperonin gene. (383) 277 
CD, (378) 43: (381) 237; (395) 160; (396) 196 
CD spectroscopy. (394) 289 
CD spectrum, (387) 81 
CD21. (381) 227 
CD26, (383) 145 
CD35 (381) 227 
CD38, (396) 327; (397) 113 
CD4, (38 I) 227 
CD4+ T cell, (393) 93 
CD40, (386) I 15 
CD44. (388) 2 I 1 
CD59. (399) 272 
cdc’, (379) 217 
Cdc42. (386) 230 
CDC48. (382) 261 
Cdk5. (378) 48 
cDNA, (378) 57; (381) 13.5: (382) 125; (384)9; (386) 128: (387) 189: 
(389) 324; (390) 81; (391) 5: (392) 71; (396) 181; (399) 339 
cDNA clone, (378) 19 
cDNA cloning, (378) 245; (381) 149; (384) 289: (387) 27, 117; (389) 
273: (391) 1.269; (392) 95. 189; (393) 259: (396) 147; (397) 83.250, 
352: (398) 170.259: (399) 295 
cDNA sequence. (388) 139; (394) 21 
CDPK-related protein kinase. (396) 147 
Cecropin, (379) 273 
P-Cell. (378) 227 
Cell adhesion. (382) 65: (384) 247; (399) 53 
Cell attachment. (396) 37 
Cell culture, (380) 257; (391) 21; (396) 177 
Cell cycle, (384) 107; (385) 34. 143; (391) 66. 175: (397) 65 
Cell death, (381) 93; (387) 78; (394) 321 
Cell differentiation, (393) 139: (394) 356 
Cell growth factor. (396) 103 
Cell growth jnhibition. (397) 215 
Cell motility, (382) 193 
Cell polarity, (392) 237 
Cell proliferation. (378) 88; (394) I59 
Cell surface, (388) 29 
Cell surface proteoglvcan. (383) 75 
Cell volume..(391) 287, 293 
Cell wall. (388) 139; (392) 184 
Cell wall invertase. (385) 17 I 
Cell wall mannan, (395) 109 
Cell-free translation. (397) I43 
Cellobiohydrolase 1. (390) 339 
Cellophane wrap, (378) 2 I Y 
Cellular delivery, (390) 3 15 
Cellular tibronectin. (391) 52 
Cellular location, (3Y2) 81 
Cellular process, (390) 1 I9 
Cellular signaling. (399) 127 
Cellular uptake. (394) 174 
Cellulase. (378) 51; (390) 339 
Cellulose. (378) 51 
Cellulose-bound synthetic peptide, (379) I22 
Cc~ntuurium rr~thrueu, (383) 264 
Central metabolism, (392) I48 
Centromere, (389) 70 
Ceramide, (378) 88: (383) 223: (390) 233; (395) 267 
Cereal, (396) 285 
Cerebellar granule cells, (391) 336 
Cerebellum, (391) 45 
58’ ‘k’. (380) I98 
c~-fbs. (379) 255 
c-fos. (381) 222 
c-Fos. (390) 47 
CFPAC, (393) 264 
CFTR, (381) 47: (393) 264 
cGMP, (385) 47; (386) 39: (393) 21 I 
cGMP cycle. (385) 185 
Channel phosphorylation. (391) 189 
Channel protein. (398) I2 
Channeling, (382) 18 
Chaperone, (379) 302; (382) 281: (385) 67; (389) 32; (399) 75 
Chaperonin. (379) 127 
CHAPS. (391) 199 
Characterization. (384) 35 
Charge neutrality, (397) 159 
Charge-transfer mechanism. (387) I 
Chelate complex formation. (392) 269 
Chelator. (378) 37: (382) 304 
Chemical cleavage, (384) 207 
Chemical cross-linking. (387) 75 
Chemical modification, (383) 55; (392) 293 
Chemical modification of reaction center, (379) 97 
Chemo-enzymatic synthesis, (379) 227 
Chemokine. (379) 265; (395) 83; (399) 43 
Chemotaxis. (388) I65 
Chemotherapy, (390) 39: (391) 61 
Chick embryo. (37’)) 82 
Chicken. (382) 183 
Chicken cystatin. (392) 277 
Chilling, (396) 152 
Chimera, (386) 21 I; (3891 174 
Chimeric protein. (389) 238 
Chimeric receptor, (384) 198; (386) Sl 
Chimeric thioredoxin. (380) I23 
Chimeric transporter. (38 1) 127 
Chiral recogniAon. (390) 339 
Chiral stationary phase. (390) 339 
Chitin binding, (396) 261 
Chitinase, (382) 186 
Chlam~~domonas, (396) 298 
Chlamydomonas reirAard/~l. (39 I ) 203 ; (396) I35 
U~lorellu, (389) 3 19 
Chlorrllu kessleri, (381) 127 
Chloride channel. (390) 207: (395) 133. 133 
Chloride channel 1. (396) 177 
Chlorc$le.ws auruntiuwc, (396) 161 
Chlorophyll, (395) 2.51: (399) 245 
Chlorophyll fluorescence, (397) I3 1 
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Chloroplast. (379) 309: (383) 196: (384) 289; (390) 85. 175; (391) 
Chloroplast ATP synthase, (395) 217 
Chloroplast fructose-I$-bisphosphatase, (380) 123 
Chloroplast nrotein import. (3961 135 
Chlororespiration, (378’) 277‘ ’ 
Chlorosome, (383) 233 
Chlorotyrosine, (379) 103 
CHO cell, (378) 121, 250: (395) 262 
CHO-K 1 cell, (386) 5 1 
3-[(3-Cho1amidopropy1)-dimethylammonio]-l-propanesulfonatc. 
29 Coatomer. (384) 65 
Cobalt, (382) 229 
Cobalt(B), (397) 159 
Coenzyme Bt2. (389) 20 
Colchtcme, (393) 86 
Cold acclimation, (382) 261 ; (389) 324 
Cold stress, (399) 245 
Collagen. (396) 279; (397) 245 
Collagen oentide. (398) 31 
Collagenase~ (37Q.126: (380) 17; (398) 31 
Collagen-induced arthritis, (378) 153 
Collectin-43, (393) 314 
Colocalization, (378) 64 
Colon carcinoma cell, (396) 3 I5 
Colony screening. (399) 3 13 
ColorhifferenceT(384) 83 
Comet assay, (394) 300 
ComK regulation, (397) 173 
Compartmentation. (386) 255 
Competence development, (397) 173 
Competitive ELISA, (397) 169 
Competitive polymerase chain reaction, (388) 155 
Competitive selection, (391) 71 
Complement, (380) 8; (386) 15; (397) 245; (399) 255.272 
Complement activation. (393) 297 
Complement factor H, (393) 297 
Complement pathway, Alternative, (393) 297 
Complement receptor, (381) 227: (397) 269 
Complementarity determining region. (399) 1 
Complementary DNA, (398) 91 
Complementation. (381) 87: (385) 91 
Complex formation, (394) 165 
Complex I. (380) 176; (381) 174; (393) 81 
Composite simple repeat. (389) 92 
Compound D 609. (381) 67 
Compound I, (389) 153 
Compound II, (389) 153 
Computer analysis, (378) 93 
Computer method, (393) 241 
Cone photoreceptor, (393) 211 
Confocal microscopy, (382) 3 1 
Confocal microspectroscopy. (397) 61 
Conformation, (379) 69. 171; (382) 26; (391) 84; (395) 53 
Conformational analysis, (384) 35 
Conformational change, (394) 330 
Conformational constraint. (387) I1 
Conformational stability, (380) 44: (391) 313; (393) 151 
Conformer, (399) 188 
Connectin. (385) 11 
Connective tissue damage, (38 1) 2 1 
Connexin43. (3971 22 
tionotoxin MVII C, (391) 232 
Consensus sequence. (390) 44; (397) 347 
Conservation analysis, (397) 225 
Conserved motif, (390) 39 
Constant, (392) 245 
Constitutive activity, (378) 27; (386) 165 
Constitutively active mutant, (399) 108 
Contactin/Fl 1. (389) 304 
Contactinhibin. (395) 170 
Convertase, (379) 113, 247; (396) 31 
Convolvulaceae, (397) 352 
Cooperative kinetics, (389) 293 
Cooperativity, (379) 25 1 
Coordination of heme, (37X) 291 
COP I-vesicle. (389) 66 
Copper. (379)‘51; (382) 189; (393) 317; (398) 248: (399) 143 
Copper active site, (384) 251 
Copper amine oxidase, (380) 183: (399) 215 
Copper oxidation, (383) 155 
Copper protein, (394) 340: (398) 23 1 
Core mutant, (398) 3 12 
Cornea] endothelium. (385) 225 
Cornea1 epithelium, (385) 225 
Coronary resistance, (396) 238 
Cortex, (389) 309 
(391) 199 
Cholecystokinin receptor, (383) 241 
Cholesterol. (388) 143; (389) 52 
Cholesteryl ester storage disease, (397) 79 
Cholinergic neuron, (396) 143 
Chondrocyte, (381) 222: (395) 179 
Chondroitin sulfate proteoglycan. (386) I69 
CHOP, (395) 143 
Choroid, (387) 63 
Chromaffin cell. (385) 159; (386) 137: (393) 185 
Chromaflin granule, (379) 273: (391) 195; (394) 83 
Chromanol. (396) 27 1 
Chromatin, (386) 75; (393) 287 
Chromatin structure, (388) 5; (395) 183 
Chromogranin, (379) 273; (394) 295 
Chromosomal localization, (381) 135: (384) 9 
Chromosomal mapping, (378) 195 
Chromosome, (394) 325; (398) 253 
Chromosome 1, (394) 17 
Chromosome 10, (399) 339 
Chromosome 14, (381) 7; (383) 219: (389) 297: (393) 19 
Chromosome 3, (398) 74 
Chromosome 4, (382) 276 
Chromosome in situ hybridization, (394) 187 
Chromosome mapping, (386) 128: (387) 117: (395) 82 
Chromosome walkine. (389) 84 
Chronic fatigue syndrome, (378) 145 
Chylomicron, (393) 253 
Chymase, (383) 170 
Chvmosin. (379) 60 
Chymosin activation, (379) 60 
Chymosin specificity, (379) 60 
Chymotrypsin, (379) 139, 143; (390) 323 
Ciclopirox olamine, (380) 209 
Cigarette smoke, (396) 2 1 
Ciliated protozoan, (383) 277 
CINC mRNA, (379) 265 
Cinnabarinic acid, (391) 144 
Ciprofibroyl-CoA, (389) 219 
Circadian rhythm, (385) 205 
Circular dichroism, (380) 73, 179; (384) 255; (388) 47; (399) 47 
Circular permutation, (378) 263 
Circulation, (382) 101 
Cisplatin, (397) 101 
Citrate synthase, (380) 152 
c-Jun, (390) 47 
CK2 pseudosubstrate, (380) 25 
Cl- conductance, (381) 47 
Cl- secretion. (381) 47: (396) 271 
i4C-Labelled tentoxin, (395) 217 
Class III transcription. (386) 43 
Clathrin-coated vesicle,‘(389) 48 
Clearance receptor, (396) 238 
Cleavable ternary complex. (396) 289 
Cleavage, (399) 158 
Cloned K+ channel, (378) 250 
Cloning, (379) 107; (392) 71; (398) 19; (399) 122 
Clostridium pasteurianum, (380) 287 
Clostridium ,verfrinpens. (395) 19 1 
Clp protease, (398)274 
ClpAP, (398) 151 
CLS2, (379) 38 
CMP-Kdo synthetase (Escherichia colij, (39 I) 157 
CMP-N-acetylneuraminic acid. (385) 197 
CMV, (379) 26 
13C-NMR, (383) 175; (397) 122 
CNS, (388) 123 
CO? hydration, (398) 322 
Corticosterone, (397) 186 
Corticotropin releasing factor, (399) 175 
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COS-7 cell, (396) 305 
Cosfus speciosus Smith, (378) 157: (389) 273 
Cotranslational folding, (399) 78 
p-Coumaric acid, (382) 73 
COUP-TF II, (391) 95 
Covalent attachment, (390) 307 
Covalent binding, (381) 35 
Covalent flavinylation, (386) 194 
Covalent inhibition, (392) 117 
Cox IV homolog, (381) 123 
CpG dinucleotide, (396) 119 
CpG island, (379) 251; (395) 11 
CpG methylation, (379) 251 
CpG suppression, (396) 119 
CPP32, (390) 299; (395) 267 
CPP32/Yama, (386) 115 
CPP32Namalapopain (393) I 
cpd, (392) 231 
c-Raf-1 kinase, (385) 131 
Crassulacean acid metabolism, (389) 314 
C-reactive protein, (388) 103 
Creatine kinase, (392) 274 
Crigler-Najjar, (390) 294 
Critical micellar concentration, (386) 243; (391) 199 
Crosslink, (393) 37 
Cross-linked duplexes, (378) 224 
Cross-linking, (394) 44; (397) 191 
Cross-species modulation, (390) 19 1 
Cross-talk of signalling pathways, (391) 131 
Crystal, (384) 215 
Crystalstructure,(379) 148: (384)211: (391) 153, 157: (394)91. 191; 
(398) 291 
a-Crystallin, (382) 281; (393) 151 
Crystallization, (382) 15: (384)219; (389) 195; (391)9: (394)201; (396) 
161; (397) 290; (399) 59 
c-ski, (397) 253 
c-snoN, (397) 253 
c-Src, (383) 165 
c-Src tyrosine kinase. (399) 63 
C-terminal domain. (393) 269 
CTL, (393) 280 
C-type lectin, (388) 211: (393) 314 
CUB domain, (379) 207; (382) 15 
Cultured cell, (378) 213 
Cultured neuron, (393) 135 
Cyanelle. (381) 153; (382) 60 
Cyanobacterial mutant. (394) 153 
Cyanobacterium, (379) 309; (383) 79; (394) 153 
Cyanogen bromide cleavage, (391) 3 17 
Cyanophoraparadosa, (381) 153 
Cyclic adenosine diphosphate ribose, (379) 227 
Cyclic ADP-ribose, (391) 117: (395) 39 
Cyclic AMP, (382) 271; (384) 97,273; (385) 233; (393) 174; (394) 39: 
(396) 276; (397) 155 
Cyclic AMP-dependent protein kinase, (396) 276 
Cyclic aristeromycin diphosphate ribose. (379) 227 
Cyclic electron flow, (378) 277 
Cyclic GMP, (391) 117 
Cyclic GMP phosphodiesterase (PDE), (381) 149 
2’,3’-Cyclic nucleotide 3’-phosphodiesterase, (386) 225 
Cyclic nucleotide-gated channel, (393) 211: (395) 77 
Cyclic peptide, (387) 201 
Cyclic tetrapeptide. (395) 217 
Cyclin, (379) 217; (397) 65 
Cyclin D I expression, (385) 143 
Cyclin-dependent kinase, (379) 217 
Cyclin-dependent kinase inhibitor, (391) 66 
c$o-(o-alanyl-N-methyheucyl), (380) 157 
Cycloheximide, (379) 279: (397) 269 
Cyclooxygenase, (395) 299 
Cyclooxygenase-2, (390) 165 
Cyclophilin, (394) 289; (398) 201 
Cycle-prolylglycine, (391) 149 
Cyclosporin A, (382) 256; (393) 86: (398) 201 
Cyclosporin synthetase. (380) 157 
Cylindrical inclusion protein, (388) 206 
B-Cylodextrin conjugation (391) 297 
CYPl19. (384) 235 
CYP2C18. (384) 281 
CYP2C19. (384) 281 
CYPZD6 genotyping, (392) 30 
Cys mutagenesis, (391) 101 
Cystathionase, (379) 94 
Cystathionin B-lyase, (379) 94 
Cystatin, (391) 109 
Cysteine, (396) 95 
Cysteine protease. (382) 6; (384) 211; (392) 35; (393) 24 
Cysteine proteinase, (388) 233; (391) 109; (392) 233.277 
Cysteine proteinase inhibitor, (395) 113 
Cysteine string protein, (380) 251; (391) 269 
Cystic fibrosis, (381) 47; (386) 123; (398) 97 
Cystic fibrosis transmembrane conductance regulator. (398) 97 
Cvtochrome. (388) 185 
Cytochrome b, (389) 25, 233 
Cytochrome b559, (381) 53 
Cytochrome b-559, (387) 33 
Cvtochrome bcl comolex. (387) 1; (389) 233 
Cytochrome hoi (399j23 
Cytochrome c oxidase. (381) 123; (382) 111, 121; (385) 53; (391) 134; 
(393) 155; (394) 340 
Cytochrome c peroxidase. comparison, (389) 153 
Cytochrome cs, (390) 59 
Cytochrome oxidase, (388) 47 
Cytochrome P450, (383) 83; (384) 235: (386) 33; (389) 268; (390) 10, 
142; (394) 21 
Cytochrome P450 BM3, (396) 196 
Cytochrome P450 (CUP). (388) 21 
Cytochrome P450( 1 IB). (397) 250 
Cytochrome P-450,,, (383) 13 
Cytochrome P-45Oscc, (378) 182 
Cytochrome subunit, (385) 209 
Cytokine, (388) 180; (389) 145; (392) 209; (395) 133; (399) 321 
Cytokine receptor, (394) 221 
Cytokinesis, (394) 25 I 
Cytokinin, (391) 175 
Cvtolvsis, (385) 96 
Cytoplasmic granule, (393) 216 
Cytoplasmic macromolecule, (390) 245 
Cytoskeleton,(378)258; (380) 198; (382) 159; (384)71,147; (386) 185; 
(388) 131; (389) 324; (393) 13; (398) 211, 303 
Cytosol. (395) 68 
Cytosolic Ca’+, (392) 143 
Cytosolic Ca?+ homeostasis. (392) 194 
Cytosolic phospholipase As, (379) 77 
Cytotoxic T lymphocyte, (387) 42 
Cytotoxicity, (383) 230; (388) 165: (389) 285; (393) 93, 105; (396) 261 
2-D crystal, (,382) 203 
2-D crvstallisation. (380) 296 
2-D electrophores&(378) 258 
3D structure. (391) 223 
Dl reaction center protein, (388) 89 
Ds dopamine receptor, (381) 257 
D96N mutant, (387) 122; (399) 25 I 
DAN-binding protein, (38 I) 103 
59 DAP, (383) 124 
Database, (398) 129 
Database annotation. (389) 96 
Daucus carom L.. (379) 97 
Daunomycin, (392) 269 
d(CG)s. (391) 153 
d(CG)s-thermospermine complex, (398) 291 
De novo methylation. (395) II 
Deacetvlation. (390) 199 
Debrisoquine 4:hydroxylase. (392) 30 
Decorin, (386) 29 
Defensin, (396) 3 19 
Degradation. (390) 15 
de&de&: (2~7) i73 
Dehydratase, (389) 20 
Dehydrin, (381) 252 
Dehydroascorbic acid, (390) 183 
Dehydrogenase, (389) 263; (399) 92 
Delaved rectifier. (389) 167 
Deleiion, (378) 286; (385) 91; (390) 99; (395) 22 
Demethylation, (395) 1 I 
Volumes 378- 399 (1996) 76 
Denaturation, (380) 179; (391) 313 
Dendrogram. (395) 286 
Dendrotoxin. (383) 26 
Density-dependent inhibition ofgrowth. (395) 170 
Dental pulp cell, (393) 193 
Denys-Drash syndrome, (393) 41 
2’-Deoxy-2’-aminouridine. (378) 224 
Deoxy-glucotropaeolin, (385) X7 
Deoxyhypusine synthase, (384) 15 1 
Deoxynucleoside kinase, (390) 39 
Deoxypyridinohne, (388) 134 
Deoxythymidine 3’.5’-bis-(p-nitrophenyl phosphate), (397) 343 
Deprotonation. (387) 1 
Desmin. (392) 255 
Desulfoferrodoxin, (385) 138 
Desulforedoxin, (385) 138 
Desuljovibrio. (385) 138; (389) 203 
Drsu&~ihrio vulguri.~ Hildenborough ferricytochrome L’~;.(, (395) 53 
Detection method, (388) 16 
Detergent, (396) 161 
Detergent insolubility. (389) 52 
Detoxification, (384) 31 
Deuterium oxide. (397) 136 
Development, (379) 82; (382) 198 
Developmental toxicity. (393) 139 
Dexamethasone, (383) 63; (391) 57: (398) 308 
Dextran sulfate, (393) 297 
DHR/PDZ domain. (396) 81 
Diabetes. (382) 234: (391) 185 
Diabetes mellitus, (382) 276: (396) 2 IX 
Diabetic angiopathy, (384) 103 
Diacylglycerol, (380) 58: (389) 13 I 
Diacylglycerol kinase (a-isozyme). (393) 48 
meso-Diaminopimelate-adding enzyme, (39 I ) 17 1 
Diaminopimelic acid analog. (39 1) 17 I 
Dianthin 30, (392) 16 
Dibutyryl cyclic AMP, (391) 95 
diC14-amidine. (380) 108 
Dicarboxylate carrier, (399) 299 
Dictyostrlium, (382) 198: (394) 751: (395) 286 
Dicfyostelium discoidrum. (386) 103 : (395) 6X 
Didemnin B, (383) 1 
Dietary cholesterol, (394) 247 
Diethylpyrocarbonate, (3X I) 1 XX 
Differential display, (383) 83; (397) 101 
Differential display PCR, (384) 4X: (386) 225 
Differential pattern of expression, (383) 208 
Differential spectrophotometry, (392) 91; (399) 99 
Differentiation. (379) 177; (382) 313; (389) 80; (395) 228 
7,8-Dihydroneopterin, (397) 263 
Dihydropyridine, (388) 150 
Dihydropyridine, U937 cell. (394) 159 
la,25-Dihydroxyvitamin D:i, (378) XX; (393) 193 
1,25-Dihydroxyvitamin D (. (392) 2 I 
Dimer, (392) 215 
Dimerization, (379) 153; (399) 117 
Dinuclear center. (397) 159 
Dioxygen, (384) 251 
Dipeptidyl aminopeptidase I, (392) 277 
Dipeptidyl peptidase IV, (383) 145 
Diphtheria toxin, (395) 245 
Direct assay, (388) 223 
Disease, (398) 129 
Disintegrin, (391) 139 
Dismutation, (394) 2 17 
Disorder, (398) 175 
Displacement curve, (392) 245 
Dissociation, (380) 118: (392) 245 
Distribution. (398) 19 
Disulfide. (386) 65 
Disulfde array. (395) 6 
Disuhide bond, (379) 139; (381) 63: (383) 93: (388) 115; (396) 285 
Disulfide bridge, (380) 8; (385) 105; (391) 139; (392) 54; (393) 241 
Disuhide mutagenesis. (382) 137 
Disuhide oxidoreductase. (398) 265 
Disuhide reagent, (379) 161 
Disuse, (390) 304 
Dityrosine, (396) 223 
Divinyl ether synthase localization. (388) I 12 
Djungarian hamster. (399) 290 
DNA, (382) 26; (392) 269 
DNA binding, (380) 127; (385) 109: (387) 117: (391) 24; (396) 253 
DNA binding domain. (389) 244 
DNA binding protein, (383) 51; (391) 1 I ; (399) 313 
DNA binding protein interaction, (395) 221 
DNA binding site. (390) 44 
DNA binding site selection, (396) 99 
DNA condensation, (390) 245 
DNA conformation. (391) 215 
DNA curvature, (393) 65 
DNA damage. (383) 150; (393) 197. 317; (394) 300 
DNA damage inducible gene, (380) 87 
DNA demethylation, (382) 313 
DNA fragmentation, (384) 162: (390) 91: (395) 183: (399) 71 
DNA ligation, (380) 73 
DNA methylation. (388) 192: (396) 119, 323 
DNA polymerase, (391) I13 
DNA polymerase a. (399) I 13 
DNA polymerase translocation. (390) 6 
DNA precursor synthesis, (390) 39 
DNA recoenition. (379) 269 
DNA repayr, (397) ‘127 
DNA replication. (386) 75; (38X) 169; (397) 97; (398) 135 
DNA secondary structure, (389) 92 
DNA strand break, (390) 153; (399) 67 
DNA structure, (393) 65; (396) 253 
DNA synthesis, (381) 67; (382) 145: (391) 257 
DnaA box, (388) 169 
DNA-binding sperm protein. (378) 115 
DNA-containing complex, (384) 177 
DNA-dependent protein kinase, (3X6) 110: (393) I 
DNA-lipid interaction, (390) 133 
DNA-PK catalytic component (~460). (393) I 
DNA-protein crosslinking, (381) 103 
DNA-protein interaction, (390) 307 
DNAse activity, (392) 16 
DNase I. (387) 132: (397) 343 
DNase I cleavage, (393) 124 
ZD-NMR. (390) 59; (398) 87 
Bl Domain, (398) 312 
Domain architecture, (385) 91 
Domain structure. (396) 90 
Domain swapping, (398) 326 
Dominant-negative mutant. (37X) 15 
Dopamine B-monooxygenase. (396) 208 
Dot blottmg, (384) 193 
Down’s syndrome, (395) 204 
Down-regulation. (383) 21 
Doxorubicin. (384) 48 
Dpl16. (37X) 272 
Drosophilu, (378) 213: (379) 212: (380) 251 
Drosophiiu 5-HTd,,,, receptor. (381 ) 233 
Drosophiiu 5-HTdn,2~s receptor, (381) 233 
Droso&ilu hydei. (388) 2 19 
Droso~hilrr r&lanogustcv. (380) 33, 161: (384) 9: (388) 219: (396) 99 
DRPLA, (399) 135 
dr.s gene, (383) 21 
Drug, (382) 26 
Drug metabolism, (397) 210 
Drug resistance, (383) 99; (396) 323: (397) 101: (399) 29, 158 
Drug targeting. (38X) I 15 
Drug toxicity, (384) 48 
Duchenne muscular dystrophy. (37X) 272: (3X3) 124 
Duplex with active internucleotide group. (390) 307 
Dynamic light scattering, (380) 179 
Dynamics, (393) 221 
Dynamin, (389) 48; (396) 62 
Dystrophin, (378) 272: (398) 259 
Dystrophin-associated glycoprotein, 35 kDa. (381) 15 
E. co/i. (381) 25; (382) 171; (385) 114; (388) 217: (397) 210; (399) 135 
E. coli extract. (382) 167 
E. co/i gene, (386) 177 
E. co/i periplasm. protein folding, (380) 194 
EA.hv 926 endothelial cell. (398) 223 
Ebselkn. (398) 179 
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Echinomycin, (380) 1 IX 
Echistatm. (387) 1 I 
Ecotin, (385) 165 
Ectoenzyme, (396) 327 
Edman degradation, (390) 199 
E-domain, (385) 114 
EEG, (392) 169 
Effector, (389) 61 
Efficiency, expression, (389) 225 
EF-hand protein, (382) 198 
EF-Tu, (382) 297 
EGF, (384) 14: (397) 253 
Eicosanoid. (389) 229 
Elastase. (385) 201; (386) 26 
Electroactive label, (390) 142 
Electroblotting, (390) 199 
Electrochemistry. (390) 142 
Electrogenic H+-transporter, (38 1) 156 
Electromobility shift assay. (383) 237 
Electron crystallographic analysis. (388) 103 
Electron microscopy, (380) 296: (396) 71 
Electron paramagnetic resonance. (379) 231; (380) 287; (381) 131: 
(385) 197: (391) 21 
Electron transfer,(380) 287: (383) 129: (385) 53,209: (390) 59; (394) 87 
Electrophoretic mobility shift assay, (389) 257 
Electrophysiology, (398) 91 
Electroporation, (389) 225 
Electrospray, (381) 77 
Electrospray ionization mass spectrometry, (380) 44; (395) 53 
Electrospray mass spectrometry. (395) 33; (396) 108 
Electrostatic interaction (385) 105 
E&sine c~racanu Gaertneri. (397) 11 
Elevation. Ca’+-dependent, (392) 289 
Elicitor, (382) 213 . 
ELISA, (388) 99; (390) 161 
ELK-l, (391) 247 
Elongation factor, (382) 18: (391) 330 
Elongation factor I, (395) 63 
Elongation factor Ts. (391) 330 
Elongation factor Tu, (391) 330: (399) 59 
Elongation factor-2, (397) 55 
Embryo, (381) 257 
Embryonic MHC. (39 1) 39 
Embryonic protein, (396) 99 
Embryonic stem cell, (381) 93 
EMSA. (385) 109 
Enamel cell, (391) 323 
Endo-( I+ 5)-u-L-Arabinanase. (398) 7 
Endocytic pathway. (379) 113 
Endocytosis, (378) 177; (389) 55: (396) 327; (399) 131 
Endocytosis of IL-8. (378) 235 
Endogenous cyclic dipeptide, (391) 149 
Endogenous excitatory amino acids. (393) 135 
Endoglucanase I, (390) 339 
Endopeptidase, (389) 55 
Endoplasmic reticulum, (379) 38; (390) 294: (392) 129 
Endopolygalacturonase, (382) 249 
Endosome, (386) 161: (389) 55 
Endosperm-specific expression. (383) 213 
Endothelialcell, (380) 21: (384) 19. 103: (389) 131: (394) 335: (396) 67 
Endothelin, (383) 37,42 
Endothelin antagonist, (383) 37 
Endothelin converting enzyme, (394) 191 
Endothelin ET.% receptor. (383) 37 
Endothelin ETB receptor, (383) 37 
Endothelin precursor, (394) 191 
Endothelin receutor. (397) 186 
Endothelin receptor antagonist. (383) 42 
Endothelin-I, (379) 7: (394) 263: (396) 238 
Endothelium. (390) 289 
Endotoxin, (381) 82: (394) 51; (399) 267 
Ene-diol, (392) 281 
Energy coupling, (397) 308 
Energy transduction, (379) 309 
Energy transfer, (383) 105; (397) 273 
2-Enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. (378) 57 
Enfamoeha hisfol~~tica. (385) 96; (393) 109 
entC, (378) 131 
Entrrococcus himr. (399) 143 
Entero-hepatic circulation. (384) 13 1 
Enterokinase. (379) 47 
Enthalpy. (398) 279 
Entropy. (398) 279 
Env. (395) 257 
mv g; I 60; (390) I 5 
Envelope glycoprotein. (379) 171 
Environmental stress, (399) 175 
Enzymatic activity, (378) 166 
Enzymatic digestion, (398) 31 
Enzymatic mechamsm, (390) 211 
Enzymatic processing. (378) 17 1 
Enzyme activation, (385) 101: (391) 121 
Enzyme catalysis, (385) 101 
Enzyme class, (395) 99 
Enzyme evolution. (382) 21: (389) 12 
Enzvme inhibition. (384) 155; (399) 183 
Enzyme kinetics: (383) 196: (385) 201: (395) 188; (399) 193 
Enzyme mechamsm, (397) 93, 343 
Enzyme regulation. (379) 309 
Enzyme-inhibitor complex. (392) 35 
Enzyme-linked immunosorbent assay, (395) 109 
Epidermal growth factor. (381) 115 
Epidermolytic hereditary palmoplantar keratoderma. (386) 149 
Epithelial cell, (396) 3 19 
Epitope tagging. (390) 137; (397) 79 
EPR. (380) 165 
EPR spectroscopy, (383) 79 
Equilibrium dialysis. (395) 2 17 
ERG3. (392) 161 
crg6, (381) 87 
Ergosterol, (392) 16 I 
ERK2. (396) 62 
Erythrocyte, (390) 25 
Erythropoietin, (387) 161 
Eschrrichiu co/i. (378) 131; (379) 94,135.295; (382) 141: (386) 5; (387) 
137;(390)53. 179.245;(392,184;(397)93;(398)151,265;(399)21. 
223. 307 
ESR, (378) 111 
ESR Spin trappmg. (379) 51 
17P-Estradiol, (392) 49 
Estradiol. (399) 33 
Estrogen, (382) 183 
Estrogen receptor, (386) 1: (390) 170: (392) 49 
Estrogen receotor mRNA. (394) 371 
ETu riceptor: (383) 42 
ETu subtype. (396) 238 
Ethacrynic acid. (39 1) I26 
Ethanol, (389) 119; (390) 153 
Ethanol production, (387) 7 
Ethanolamine analogue, (381) 67 
Etheno-adenine nucleotide, (391) 195 
Ethidium bromide, (388) 99; (391) 215 
I-Ethyl-3-(3-dimethylaminopropyl)carbodiimide, (383) 55 
N-Ethvlmaleimide-sensitive factor. (394) 83 
4-Ethylphenol methylene hydroxylase, (381) 140 
Etiolation, (384) 285 
Etioplast, (395) 251 
Euglycaemic-hyperinsulinaemic clamp, (396) 53 
Eukaryote, (396) 18 1 
Eukaryotic expression. (382) 285 
Eukaryotic initiatron factor 5A. (378) 195; (380) 209; (384) 151 
Eukaryotic transcrrptional regulation, (390) 191 
Evolution. (378)232; (381) 39; (382)60.319; (383)46; (384)235; (387) 
94. 161; (388) 219; (390) 119: (394) 66; (395) 58; (397) 83 
Evolutionary change, (389) 249 
Excitation energy transfer, (383) 233 
Excitation-contraction coupling. (380) 267; (382) 31; (394) 330 
Exciton interactions, (387) 81 
Exocvtic nathwav. I 379) 113 
Exocytosjs, (379jl5; (3k5) 176; (386) 123. 137; (391) 263: (393) 185; 
(394) 109; (396) 227; (398) 67 
Exbenzyme production, (397) 173 
Exon 11. (381) 7 
Exopolygalacturonase. (382) 249 
Expressed sequence tag. (392) 95 
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Expression, (378) 245: (379) 55; (380) 103; (384) 289; (389) 238; (392) 
259: (399) 95 
Expression in E. co/i, (381) 217; (386) 72 
Expression in liver cells, (387) 27 
Expression system, (390) 265; (391) 282 
Extension growth. (384) 285 
Extracellular ATP, (387) 149 
Extracellular matrix, (379) 63; (387) 36 
Extracellular proteolysis, (393) 3 I 
Extracellular signal-regulated kinase, (380) 113; (394) 34 
F”F1, (382) 171 
Fo FI -ATPase, (392) I 10 
F,. (397) 308 
FL-ATPase. (397) I22 
F1 ATPase: Metal-binding site. (379) 231 
FI Fo-ATP synthase, (399) 26 
F26G, (378) 157 
Facilitator olieonucleotide. (382) 1 I6 
F-actin, (380)281; (395) I ii 
F-actin binding. (397) 191 
Factor IX, (392) !205 ’ 
Factor VIIa. (385) 241 
FAD, (386) 194 
Falciparum malaria. (380) 147 
Farnesol, (379) 43 
Farnesylation, (378) 15 
Fas, (390) 233; (395) 267 
FAS, fatty acid synthase. (380) 204 
Fatty acid, (382) 239: (386) 252; (391) 134: (393) 174; (399) 310 
Fatty acid binding protein, (397) 117 
Fatty acid hydroperoxide lyase, (394) 2 I 
Fatty acid oxidation, (384) 58 
Fatty acid synthesis. (388) 66 
Fatty acylation, (380) 251: (388) 143 
Fey, (394) 237 
FqRI/CD64, (386) 239 
Fe65, (397) 197 
Femtosecond spectroscopy. (383) 129 
Ferredoxin-NADP’ reductase. (378) 277 
Ferricytochrome c,~~:(. (389) 203 
Ferritin, (381) 131; (382) 145; (390) 261; (394) 31 I 
Fe& cluster, (391) 101 
Fetal hepatocyte, (384) 14 
Fetal tissue, (397) 338 
Fetus, (393) 253 
Ffh protein, (395) 160 
Fibril, (379) 203 
Fibrillin. (386) 169 
Fibrillin-1, (384) 247 
Fibrinogen, (378) 79; (385) 81; (386) 82: (391) 84 
Fibrinolysis, (393) 31 
Fibroblast, (379) 157; (394) 213 
Fibroblast (Swiss 3T3). (391) 219 
Fibronectin type II domain. (399) 147 
Fidelity, (391) 257 
Firefly, (384) 83 
Firefly luciferase, (380) 142; (395) 188 
Fish therapeutic, (383) 25 1 
Fission, (384) 65 
Fission yeast, (378) 207: (379) 217; (392) 237 
FK506, (379) 38 
Flagellin gene, (396) 2 I3 
Flagellum, (393) 27: (396) 213. 298; 
5’-Flanking region. (384) 281 
Flash induced fluorescence. (381) 53 
Flash photolysis, (383) 13 
Flaveria, (396) 152 
Flaveria trinervia. (392) 285 
Flavin, (389) 20 . 
Flavin reductase, (387) 137 
Flavoenzyme, (386) 194 
Flavohaemoglobin. (382) 141 
Flavoprotein, (383) 79 
Flow cytometry. (386) 141 
Fluidity, (380) 165 
Fluorescence, (378) 69: (382) 304; (388) 99: (389) I1 I, 238; (390) 203 
Fluorescence in situ hybridisation. (396) 47 
Fluorescence lifetime, (386) I8 1 
Fluorescence microscopy. (380) 13: (396) 7 I 
Fluorescence quenching. (390) 221 
Fluorescence spectroscopy, (380) 73 
Fluorescence spectrum, (380) 157 
Fluorescence-activated cell sorting. (390) 327 
Fluorescent probe. (388) 16 
Fluorometry, (383) 99 
Focal adhesion. (399) 103 
Focal adhesion k‘inase, (386) 185 
Focal contact, (399) 103 
Folding, (380) 157 
Folding problem. (390) 249 
Foot-and-mouth-disease virus, (388) 39; (397) 169 
Footprinting, (379) 269; (394) 71 
Force curve measurement, (385) 29 
Force-distance curve, (390) 161 
N-Formylkynurenine, (389) 136 
Formyl-Met-Leu-Phe, (395) 293 
Forskolin. (382) 271: (396) 309 
Fiirster energy transfer. (386) 181 
Fourier analysis, (393) 65 
Fourier transform infrared spectroscopy. (384) 255; (395) 195 
FRAP. (396) 165 
Free energy mapping, (384) 87 
Free energy method, (384) 87 
Free radical, (380) 183; (389) 136,229 
Freeze-fracture reolica labeling. (395) 29 
Frog, (387) 27: (344) 295 - 
Fructan. (385) 39 
Fructan-fructan I -fructosyltransferase, (385) 39 
Fructose. (378) 185 
Fructose 2,6-bisphosphate, (393) 167 
Fructose-l .h-bisphosDhatase. (389) 249 
Fructose-2,6-bisphosphatase, (393) 167 
Fruit, (394) 21 
FruR, (383) 191 
FTIR. (382) 26 
FTIR spectroscopy, (385) 53 
FTIR. Fourier-transform infrared.. (383) I3 
FtsH. (399) 26 
L-Fuculose 1 -phosphate aldolase. (392) 28 I 
Fullerene. (389) 111; (393) I39 
Full-length cDNA, (383) 208 
Fumarate reductase, (389) 25 
Functional class, (389) 96 
Functional cloning. (393) 89 
Functional expression. (380) 229: (396) 26 
Fungi, (390) 261 
Fur:‘, (379) 21 
6-Furfuryladenine, (393) 197 
Furin, (378) 227: (379) 113. 247; (386) 201 
Furostanol glycoside, (378) 157 
Furostanol glycoside 26-O-p-glucosidase (F26G), (389) 273 
Fuscopeptin, (381) 213 
Fusicoccin receptor (382) 293 
Fusion protein, (384) 193, 215; (387) 23: (390) 170 
Fyn. (397) 183 
Fyn tyrosine kinase. (378) 7 
Gprotein.(379)31; (381)98.233: (382) 159; (386) 165; (389)61; (399) 
211 
G protein subunit, (390) 217 
G protein-coupled receptor. (378) 27,74; (381) 58,257; (386)219; (397) 
201; (399) 9, 188 
G protein-coupled receptor kinase. (384) 227 
Cl/GO phase, (397) 253 
GABA receptor. (380) 257 
GADDI53, (395) 143 
Gaegurin. (392) 309 
GALll, (398) 113 
Galactose, (389) 174 
D-Galactose, (381) 127 
a-Galactosidase, (393) 74 
P-Galactosidase fusion, (381) 29 
Galactosylhydroxylysine, (388) 134 
o-Galacturonic acid, (398) 297 
Gallus domesticus, (399) I98 
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Gamma-interferon receptor. (382) 79 
Ganghonic nAChR, (397) 39 
Ganghoside, (378) 253: (386) 11 
Ganghoside GMl. (391) 336 
Ganghoside GM3, (38X) 128 
Ganghoside metabolism, (391) 336 
Ganghoside shedding, (386) 11 
Ganglioside transfer, (386) 11 
Gap junction, (392) 225: (397) 22 
GAPDH. glyceraldehyde-3-phosphate dehydrogenase.. (380) 204 
Gas chromatography-mass spectrometry. (394) 2 17 
Gas6, (387) 75,7X 
Gastric chief cell. (381) 208 
Gastric parietal ceil, (381) 208 
Gastrin, (37X) 74: (386) 128 
Gastrin-binding protein. (384) 58 
Gastrointestinal tract, (38X) 155 
Gating current, (388) 59 
GB virus, (37X) 232 
GPy dimers, (399) 211 
gClqR, (399) 255 
Gem, (393) 201 
GCN4 motif. (383) 2 I3 
G-CSF. (386) 239 
Gel filtration, (394) 316 
Gel mobility shift. (394) 5 
Gel retardation, (388) 53 
Gel retardation assay, (393) 259 
Gel squeezing, (393) 13 1 
Gelatinase, (378) 126: (383) 241: (391) 52 
Gelatinase A. (380) 53: (397) 277 
Gelonin. (392) 16 
Gelonin-transferrin conjugate, (396) 57 
Gelsolin, (397) 191 
Gene, (386) 128,211 
Gene characterization. (390) 145 
Genecloning, (380) 87: (386) 215: (387) 189 
Gene conversion. (382) 319 
Gene disruption, (384) 151 
Gene dosage. (395) 58 
Gene dupl&ation, (392) 30; (395) 82 
Gene expression, (379) 181. 279: (380) 93, 224. 257: (381) 58; (382) I. 
145; (383) 267.277; (384) 285: (385) 109; (386) 225: (391) 79, 104; 
(392) 189: (393) 113: (394) 9, 17. 51. 285; (395) 82. 299; (397) 155: 
(398) 135.259 
Gene family, (390) 145 
Gene function. (389) 84 
Gene induction, (395) I 19 
Gene mapping. (396) 2 13 
Generegulation,(383)63;(384)131:(385)34,233:(391)95.131;(397) 
149; (399) 14 
Gene splicing, (393) I9 
Genestructure, (381) 58; (383) 277: (389) 213: (396) 333 
Gene structure analysis, (392) 63 
Gene synthesis, (399) 283 
Gene therapy, (390) 191: (399) 37 
Gene transfection, (396) 7 I ; (397) 207 
Gene transfer, (389) 225 
Genetic disease, (399) 75 
Genistein. (380) 83 
Genome composition, (389) 96 
Genome diversity, (396) 213 
Genome organization. (384) 222 
Genome sequencing, (389) X4,88; (396) I 
Genomic DNA structure, (398) 165 
Genomic sequencing, (388) 192 
Gentamicin, (394) 307 
GF14. (391) 252 
GFP, (382) 256 
GHs cell, (386) 39 
GHRH, (394) I 
GHRH receptor. (394) I 
Giardiu lamblia. (378) 240 
Gibberellic acid. (385) 189 
Gibberellin-binding protein, (384) 167 
Gla domain. (385) 241; (392) 205 
Gla mutation, (385) 241 
Gha, (393) 201 
Gliadin. (396) 285 
Glial cells missing, (393) 201 
Gliogenesis, (393) 201 
Ghoma, (393) 216 
Global expressional regulation. (386) I77 
Global fold. (37X) 190; (391) 302 
Globotriasylceramide, (393) 74 
Glomus mossme. (385) 189 
GLP-I receptor, (398) 43 
Glucagon-like peptide 1. (393) 248 
Glucagon-like oeotide 1 receptor mRNA. (393) 248 
Glucan affinity p&fication, i381) 203 
P-Glucan-binding protein, (38 I) 203 
Glucocorticoid, (39X) 308: (399) 3 IO 
Glucocorticoid receptor, (381) 177: (389) 244 
Glucokinase, (393) 60 
Gluconate transport (395) 272 
Gluconeogenesis. (389) 249; (390) 183 
Gluconokinase. (394) 14 
Glucose. (378) 185; (381) 77; (382)43: (389) 174 
Glucose catabolism, (385) 233 
Glucose dehydrogenase, (383) 227 
Glucose inactivation, (385) 43 
Glucose kinetics. (396) 53 
Glucose metabolism, (393) 60 
Glucose regulated protein. (380) 68 
Glucose transport, (387) 193: (388) 26: (393) 179 
Glucose&phosphatase. (383) 63 
!3-Ghtcosidase, (378) 93. 157 
Glucosylated aminophospholipid, (38 I ) 77 
Glucosylceramide, (394) 129 
Glucosvltransferase. (378) 263 
Glucurbnyl transferase, (395) 174 
E-(y-Glu)-Lys, (390) 145 
GLUT1 transporter, (396) 2 I8 
Glutamate. (386) 189; (392) 71. 143: (394) 321 
Glutamate neurotoxicity, (397) 230 
Glutamate phosphoanaloaue, (382) 167 
Glutamate receptor, (39031157: (394) 141 
Glutamic acid. (397) 122 
Glutamine. (394) 353 
Glutamine biosynthesis. (393) 205 
y-Glutamylcysteine synthetase. (396) 21 
y-Glutamyltranspeptidase. (394) 258 
Glutaredoxin. (378) 69 
Glutathione. (381) 12, 39: (382) 223; (388) 173: (390) 142, 183; (391) 
76. 313: (396) 21,95; (397) 293 
Glutathione conjugate, (384) 3 I 
Glutathione peroxidase, (38 1) 12 
Glutathione peroxidase (rat hepatoma cell), (387) 157 
Glutathione S-transferase, (391) 126. 313 
Glutathione-related enzyme. (391) 76 
0-Glycan, (378) 2 13 
Glycan, (379) 171 
Glvcation. (382) 234 
Glycine decarboxylase complex, (386) 174 
Givcinrmox. (383) 83; (398) 155 
Giycogen, (37X) 32 
Glycogen metabolism. (399) 339 
Glycogen phosphorylase, (382) 43 
Glycogen synthase, (378) 32 
Glycogenolysis, (388) 173 
N-Glycolylneuraminic acid. (385) 197 
Glycolysis, (389) 15; (390) 25. 229; (393) 167; (395) 225 
Glycolytic enzyme induction, (391) 35 
Glycopeptide, (393) 280 
Glycoprotein IIb-IIIa, (391) X4 
Glvcoorotein receptor. (395) 103 
Glycosaminoglycan. (3X7) 109: (389) 304 
Glycosaminoglycan biosynthesis. (386) 29 
Glycosphingolipid, (388) 29; (394) 129 
Glycosyl hydrolase family, (398) 7 
Glycosylation, (383) 255; (396) 26,223; (397) 79, 321; (399) 272 
0-Glycosylation, (399) 147 
Glycosylgalactosylhydroxylysine, (38X) 134 
Glycosyhrdnsferase, (395) 68 
G<ycyrrhizin, (391) 238 
Glycyrrhizin-binding lipoxygenase, (391) 238 
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Glyoxylate cycle, (390) 258 
GM,, (383) 223 
gntK gene, (394) 14 
gnl V gene, (394) 14 
Golden Syrian hamster liver. (394) 247 
Golgi. (392) 194 
Golgi apparatus. (382) 149; (389) 66; (390) 15 
Gonadotropin, (388) 21 
gpl20. (384) 135 
i&130, (394) 221: (395) 235; (399) 131 
GPI-anchored protein. (38 I) I 
GPIIbIIIa, (382) 159 i 
G-protein. (378) I ; (381) 244: (386) 185; (387) 141; (389) 186; (3983 97 
G-protein heterotrimer. (380) I37 
G-protein-coupled K ’ channel. (390) 63 
G-protein-coupled receptors, (384) 260 
Gramineae, (389) 324 
Gram-positive bacteria. (389) 84 
Granule, (379) 203 
Granulocyte. (398) 74 
Granulosa cell, (394) 47 
Grb2, (378) 74 
GRB-2, (379) 244 
Green alga, (396) 298 
Green bacteria. (383) 233 
Green fluorescent protein, (384) 193: (389) 44. 238; (393) 179 
Greening, (395) 251 
Gnffonia simplicifolia, (390) 27 I 
GroEL. (380) 15-; (381) 161 
GroES, (381) 161 
Group II. (394) 55 
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GSK-3, (392) 153 
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GTP hydrolysis, (385) 22 1; (390) 69 
GTPase, (389) 48: (390) 69 
GTPase activity. (396) 62; (398) 97 
GTPase-activating proteins, (383) 181 
GTP-binding protein. (379) 260 
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Guanosine triphosphate. (398) 97 
Guanylate binding, (390) 69 
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Guanylate kinase, (385) 185 
Guanylin. (398) 170 
Guanylyl cyclase. (384) 75 
Guinea pig, (378) 57 
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Gymnosperm, (383) 46: (387) 94 
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Hi/e- stoichiometry, (382) 121 
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H-2K”, (387) 42 
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Halophile, (383) 227 
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hBD-I, (396) 319 
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PhCG. (387) 23 
HCV, (378) 232 
H-DNA configuration. (389) 93 
HDV ribozyme. (394) 132 
Heart. (358) 123: (391) 45; (396) 233 
Heat shock, (378) 32; (380) 33: (382) 229; (390) 113; (392) 100; (399) 
259 
Heat shock element. (385) 25 
Heat shock factor, (385) 25 
Heat shock protein, (380) 68; (391) 21; (393) 151; (395) 133 
Heat shock protein 60 gene. (383) I50 
Heat shock protein-90, (378) I I5 
Heat-induced protein aggregation. (380) 142 
Heat-labile enterotoxin. (381 j 63 
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(384) 75 
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HeLa cell, (379) 77; (383) 150 
Hr1irmthu.r tuhuosus, (385) 39 
Helicobactrr p)lori, (399) 127 
a-Helix, (392) 309; (395) I60 
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Helix geometry, (385) IS 
Helix length effect, (399) 47 
Helix-loop-helix, (393) 113 
Helix-turn-helix motif. (389) 28 I 
Helminth. (390) 21 
Hemaeelutinin, (390) 315 
Hematopoietic progenitor. (391) 279 
Hematopoietic stem/progenitor cells, (391) 5 
Heme. (393) 189; (395) 33 
Heme environment. (396) 196 
Heme enzyme, (378) 291 
Heme oxygenase. (382) 229; (395) 299 
Heme protein, (389) 25 
Hemocvanin, (384) 251 
Hemoglobin, (382) 37, 141: (390) 25 
Hemolytic activity, (395) 48 
Hemopexin, (378) 126: (383) 72 
Hemopexin domain, (398) 3 I 
Hemorphin, (382) 37 
Hemozoin. (388) 119; (393) 189 
Heparan sulfate, (387) 109 
Heparin. (380) 25; (383) 155; (389) 304 
Heparin proteoglycan, (383) 170 
Heparin-bindjng mapping, (379) 207 
Heparin-binding protein, (399) 147 
Hepatic microsomal triglyceride transfer protein, (394) 247 
Hepatitis C virus, (378) 37 
Hepatocyte. (382) 256: (383) 267: (391 j 57: (393) 60; (394) 353 
HepG2 cell, (381) 177 
HERG. (385) 77 
12-HETE, (395) 148 
15-HETE, (395) 148 
Heterologous expression, (394) 268: (397) 210 
Heterologous gene expression. (386) 5 
Heterologous protein expression, (379) 135 
Heteromultimer, (378) 64; (386) 211: (399) 177 
Heteronuclear NMR, (383) 201 
Heterotrimer, (398) 31 
Heterotrophic nitrification. (387) 71 
Hexokinase. (378) 185: (393) 60 
Hexokinase type I, (391) 9 
Hexuronic acid, (386) 247 
HGF. (384) 14 
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High-performance liquid chromatography, (382) 37 
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Histidine, (394) 349 
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Histidine modification. (38 1) 188 
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Histidine tag. (396) 26 
Histone acetylation, (386) 75: (393) 287 
Histone acetyltransferase, (386) 75 
Histone deacetylase, (393) 287 
Histone H4, (388) 219 
Histone hyperacetylation, (395) 183 
Histone replacement gene. (388) 219 
HIT cells, (395) 137 
HIV, (381) 227; (391) 257; (393) 69; (397) 7; (398) 
HIV neurotoxicity. (384) 135 
HIV reverse transcriptase, (390) 6 
HIV-l, (379) 171; (3‘83) 145; (384) 255: (390) 15: (393) 93. 105 
HIV-l Gag polyprotein, (394) 289 
HIV-l protease inhibitor, (384) 87 
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HMGl protein type, (386) 95 
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Homeodomain, (389) 35: (398) 279; (399) 140 
Homeogene, (380) 103 
Homology, (382) 164: (387) 161 
Hordeum vulgare. (394) 165 
Hormone binding domain, (384) 112 
Hormone synthesis, (396) 223 
Hormone-sensitive lipase, (396) 90 
Horseradish peroxidase, (378) 203 
Host defense, (398) 146 
HpaIIIPCR assay, (396) 323 
HPLC, (380) 29 
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HSFI. (399) 259 
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Hsp27, (392) 100 
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Hsp70, (391) 185 
Hsp90a, (385) 25 
~-HT~A receptor, (391) 199 
HTLV-1, (396) 47 
Humaq(381) 165;(386)26,87; (389)213: (390)69,265: (392)49, 
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Human 26s protease, (381) 143 
Human adrenocorticotropic hormone. (379) 47 
Human alcohol dehydrogenase, (397) 338 
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Human cone photoreceptor, (382) 105 
Human cone pigment, (396) 26 
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Human DDR gene, (398) 165 
Human endothelial cell. (388) 180 
Human erythrocyte. (379) 107 
Human erythrocyte band 3. (382) 203 
Human fibroblast, (378) 61: (398) 187 
Human gene. (393) 211 
Human genome, (398) 129 
Human growth hormone. (387) 167 
Human hepatoma cell line, (390) 29 
Human immunodeliciency virus, (396) 43 
Human immunodeficiency virus type 1, (378) 43; (394) 9; (395) 257 
Human intestine, (398) 135 
Human keratinocyte, (378) 88 
Human kidney. (386) 156 
Human lymphocytes. (384) 97 
Human mesangial cells, (394) 273 
Human mutation databases, (396) 119 
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Human pancreas, (384) 260 
Human peripheral blood lymphocyte, (383) 18 
Human pituitary, (386) 219 
Human placenta, (399) 113. 227 
Human platelet, (383) 165 
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Human retina, (381) 149 
Human skin. (381) 199 
Human splicing factor PSF, (389) 191 
Human stomach, (381) 208 
Human T cell leukaemia virus 1, (392) 220 
Human testis, (382) 276 
Human thrombomodulin gene. (384) 207 
Human tracheal gland cell, (386) 123 
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Huntington’s disease, (399) 135 
HUPl. (381) 127 
Hyaluronate, (388) 211 
Hyaluronic acid, (383) 72 
Hybrid depletion, (392) 25 
Hybrid proteins, (386) 72 
Hybridization, (381) 195; (392) I14 
Hybridization (in situ), (379) 239 
Hydration state, (394) 353 
Hydride transfer, (397) 93 
Hydrochloric acid, (397) 45 
Hydrogel microsphere, (397) 70 
Hydrogen bonded network. (398) 333 
Hydrogen exchange rate, (383) 191 
Hidrogen metabolism, (394) 153 
Hydrogen peroxide: (381) 39; (383) 150; (386) 252: (387) 171; (388) 
228; (389) 285; (390) 91; (395) 43; (399) 21 
Hydrogen/deuterium exchange, (380) 44; (395) 53 
Hydrogen/potassium leak, (394) 61 
Hydrogenase, (383) 79; (389) 126; (394) 153 
Hydrogenase (E. cob). (392) 8 1 
Hydrolysis, (382) 249; (399) 303 
Hvdrolvsis mechanism. (398) 7 
H$drophobic F,, subunit, (390) 34 
Hydrophobic interaction, (382) 289 
Hydrophobic label, (380) 133 
N-Hydroxy-2-aminofluorene. (389) 233 
2-Hydroxyadenine, (391) 113 
3-Hvdroxvanthranilate. (391) 144 
m-Hydroxybenzoyl-CoA‘, (383) 264 
4-Hydroxybutyryl-CoA, (389) 20 
(R)-2-Hydroxyglutaryl-Co.4, (389) 20 
3-Hydroxyisobutyrate, (389) 263 
Hydroxyl radical, (379) 51 
Hydroxyl radical scavenger. (392) 40 
Hydroxylase, (385) 197 
24-Hydroxylase, (393) 77 
24-Hydroxylation, (390) 10 
4-Hydroxynonenal, (388) 119 
4-Hydroxyphenylpyruvate dioxygenase. (393) 269 
Hydroxyproline, (396) 279 
5-Hvdroxwalervl-CoA. (389) 20 
Hyierosniolarit;. (386) i30; i391) 287 
Hvnerosmosis. (391) 293 
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Hypertensive rat, (383) 42 
Hyperthermophile, (394) 66 
Hyperthermophilic archaeon. (392) 148 
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Hypoxia, (382) 229; (387) I6 I 
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Hypusine formation (378) 195 
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IL-1 receptor accessory protein (IL- 1 R AcP). (39 I ) IO4 
IL-IO, (394) 117 
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IL-3 dependence, (37Y) 244 
IL4Rcx. (393) 53 
IL-8 Internalization, (378) 235 
IL-8 receptor, (378) 235 
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Imidazole, (381) 140 
Imidazoleacrylic acids, (394) 361 
Immediate early baculovirus promoter, (380) 257 
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Immune system, (390) 78 
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Immunoblotting, (378) 199; (383) 99: (386) 72: (394) 1 
Immunocytochemistry. (385) 159 
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Immunoglobulin E. (399) 295 
Immunogold electron microscopy. (388) I I 
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39 
Immunoliposome, (395) 245: (399) 232 
Immunomodulation, (394) 39: (399) 1 j3 
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Immunotoxin. (392) I66 
Import receptor, (382) 153 
Import, in vitro. (381) 153 
Imprinted gene, (395) 1 I 
Impulse pattern, (399) 220 
In situ hybridization. (384) 78: (386) 156; (387) 11.3: (388) 155 
In vitro, (379) 203: (382) 297; (394) 233 
In vitro mvoaenesis. (397) 253 
In vitro phage assembly. (397) 143 
In vitro splicing, (384) 222 
In vitro transcription. (384) 222 
In vivo, (394) 233 
In vivo assay, (390) 53 
In vivo modulation. (395) 170 
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Inactivation. (378) 250 
Inclusion body, (381) I I I : (392) 304; (394) 3 I I 
Incomplete factorial design. (384) 2 19 
Indolicidin. (395) 48 - 
Induciblenitricoxidesynthase, (379) 135: (385)4: (391) 181 
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Infection, (384) I28 
Infectivity, (397) 143 
lniluenia virus, (390) 315; (392) 59 
Infrared. (383) 13; (384) 35: (386) 21 
Inherited retinal disease. (385) 47 
Inhibition, (380) 53: (382) 323; (390) 203: (393) 24; (396) 43 
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Inhibitor, (378) 37: (387) 127: (396) 285 
Inhibitor protein, (398) 26 
Inhibitors of CK2, (380) 25 
Inhibitory antibodies, (382) 265 
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Initiator. 1398) I 13 
Inorganic phosphate. (388) 223 
Inorganic pyrophosphatase, (392) 9 I ; (3Y9) 99 
iNOS promoter, (394) 263 
INOS regulation, (394) 263 
niro-lnositol, (395) 174 
lnositol trisphosphate, (390) 149: (391) 117 
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lns( 1.4,5)P.r. (393) 109 
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Insect cell (Sf9), (381) 233 
Insertion. (386) 243: (390) 99 
Insulin. (380) 204; (381) 67, 177: (383) 63: (384) 181.273; (388) 26; 
(392) 66. 153; (393) 77. 179; (395) 241: (396) 218; (399) 333 
Insulin production. (399) 37 
Insulin receptor, (380) Sg 
Insulin resistance, (382) 43 
Insulin secretion, (379) 21: (396) 53 
Insulin-dependent diabetes mellitus. (385) 4 
Insulin-like growth factor. (388) 155: (394) 25: (398) 187 
Insulin-like growth factor binding protein, (398) 187 
Insulin-like growth factor binding protein-3, (392) 21 
Insulin-like growth factor binding protein-5. (392) 21 
Insulin-like growth factor I. (392) 21 
Insulinoma, (387)47: (391) 189 
Insulin-producing cell. (385) 4 
Integral membrane protein, (390) 137 
lntegrase. (398) I75 
Integration host factor. (382) 141 
Integrational vector, (389) 84 
lntegrin. (3S4) 247; (391) 84: (3Y6) 37; (399) 53 
lntearin ari&. (387) I I 
Integrin c&$3, (391) 139 
Integrin avb3, (391) 139 
lntegrin GPlIb/llIa. (378) 79 
Interaction site, (380) 272 
Intercellular communication, (397) 22 
Intercellular signaling, (386) II 
Interferon, (381) 32; (390) 69 
Interferon-y, (387) 109: (394) 137 
lnterleukin, (394) 273 
lnterleukm la. (392) 175 
lnterleukin 1 P-converting enzyme. (399) I58 
Interleukin receptor, (384) 1 
Interleukin-1, (394) 137 
lnterleukin-1 receptor (IL-IR). (391) 104 
Interleukin-10. (394) 365 
lnterleukin-13, (385) 25 
Interleukin-l/3, (397) 108 
Interleukin-l/3 converting enzyme. (395) 267 
Interleukin-2, (385) 25 
Interleukin-3, (391) 279 
lnterleukin-4. (385) 25 
lnterleukin-6, (379) 122: (395) 235: (3Y9) I31 
lnterleukin-6 receptor. (379) I22 
lnterleukin-8, (378) 235: (398) 223: (399) 43 
Intermediate filament, (392) 255 
Intermembrane space, (386) 255 
Internal ribosome entry site. (392) 720 
Intestinal absorption, (394) 196 
Intestinal glucose uptake. (396) 218 
Intestine, (393) 253 
Intracellular Ca”. (386) 123: (397) 298 
Intracellular Ca” buffer. (378) 12 I 
Intracellular calcium. (383) 59: (395) 77 
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Intramolecular binding, (382) 289 
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Intraperitoneal therapy. (395) 103 
Intrinsic binding activity, (398) 43 
Intron, (379) 212; (384) 243; (390) 99; (392) 63 
Intron/exon structure, (387) 94 
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Intronless gene. (394) 325 
Inulin, (385) 39 
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Inverse agonist, (3993 108 
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Inwardly rectifying K+ channel, (386) 2 I I : (399) 172 
Inwardly rectifying potassium channel, (379) 239 
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Ion channel, (383) 26; (390) 280: (398) 91 
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Ion permeability, (390) 63 
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Ionic current. (394) 335 
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Ionizing radiation. (380) 87 
Jota toxin, (395) 191 
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Iron metabolism. (390) 261 
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Iron transport, (396) 243 
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JS30, (390) 53 
Jschemia-reperfusion. (382) 101; (391) 76; (396) 233 
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1s~. (396) 27 1 
Islet amyloid polypeptide, (378) 227; (379) 203 
Islet neogenesis, (378) 219 
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Isochore family, (390) 99 
Isochorismate hvdroxvmutase. (378) 131 
Isochorismate synthase. (378) 13 1 
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Isoform specificity, (398) 26 
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Isomerase, (389) 145 
cisltruns Isomerization. (387) 201 
Isopeptidase. (390) 145 
Isoprenoid, (388) 80 
Isoprenoid synthesis regulation, (379) 43 
Isotope exchange, (378) 140 
Isotope fractionation, (386) 174 
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Itk. (398) 217 
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Jasmonate-induced protein. (383) 83 
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Jun N-terminal kinase, (394) 273 
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Jurkat cell. (393) 1 
K+ channel. (378) 19; (379) 31: (381) 71; (385) 77: (390) 
K + channel, voltage-gated. (391) 282 
K current. (379) 236 
K562 cell line. (397) 61 
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75-kDa type 2 TNF receptor, (379) 157 
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Keratin intermediate filament, (386) I49 
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a-Ketoglutarate dehydrogenase. (382) 167 
a-Ketoglutarate phosphoanalogue. (382) 167 
a-Ketoisocaproate dioxygenase. (393) 269 
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Kex2-like protease, (386) 201 
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Kidnev. (394) 1 
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Kinase, (388) 177; (394) 96; (396) I89 
Kinase anchor protein. (382) 93 
Kinase specificity. (399) 333 
Kinase substrate; (399) 333 
Kinetic isotope effect, (398) 333 
Kinetically influential mutant, (392) 35 
Kinetics,(378)286: (383) 185; (386)99; (387) 58: (391) 109; (392)21 
(393) 314; (395) 113; (399) 99. I13 
Kinetin, (393) 197 
Kinetochore, (389) 70 
Kinetoplast, (381) 123 
Kinin. (399) 255 
Kininogen, (391) 109 
Kininogen binding protein. (399) 255 
Kink, (392) 309 
Kirromvcin. (382) 297: (399) 59 
Knob protein, (380) 147 
Knockout mice, (389) 3 
KOR-3, (395) 207 
KSMP. (382) 265 
Ku, (382) 313 
Ku protein, (393) I 
Kupffer cell. (391) 287. 293 
Kv. (399) 177 
Kynurenine. (389) I36 
L7/L12 protein, (379) 291 
Lacrimal. (391) 117 
a-Lactalbumin, (386) 21: (394) 91 
P-Lactam antibiotic. (392) 25; (394) I96 
Lactase. (398) 135 
Lactate. (382) 43; (392) 295 
Lactate dehydrogenase. (399) 193 
Lactoferricin. (382) I75 
Lactoferrin, (382) 175 
B-Lactoglobulin. (381) 237 
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Lamin A gene. (392) 137 . 
Laminin, (396) 37 
Lamprey. (394) 187 
Lanthionine-containing polypeptide, (391) 317 
Lantibiotic, (390) 129 
Laser flash photolvsis. (380) 183 
Last universal ancestor, (390) I19 
Late stationary phase, (386) 177 
Latex, (391) 287 
LBP. (399) 267 
Lck. (398) 217 
LDL, (392) 45 
Leader peptidase. (399) 307 
Leadzyme, (393) 97 
Leaf margin, (379) 1 I7 
Leaf senescence, (382) 309 
Lectin, (390) 271; (396) 261; (397) 352 
63 : (396) 27 I Lectin biodistribution. (395) I03 
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Leptin receptor, (387) 113 
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Leucine catabolism, (383) 175 
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LHRHfGnRH receptor transcript, (379) 186 
Librarv. (398) 312 
Liddle’s syndrome, (384) 1 
Ligand binding. (391) 3 13; (399) 264 
Ligand exchange; (380) 287‘ 
Ligand-protein interaction. (392) 245 
Light. (384) 285 
Light activation, (392) 121 
Light emitting, (384) 83 
Light intensity dependence, (386) 55; (398) 235 
Light regulation, (388) 89 
Light-activation, (382) 137 
Light-harvesting antenna, (383) 233 
Light-Harvesting Complex, (399) 245 
Lignin degradation, (391) 144 
LIM motif, (396) 81; (399) 117 
Limb-girdle muscular dystrophy, (38 1) 15 
Limited proteolysis, (384) 117 
LIMK, (396) 81; (399) 117 
Limulus, (393) 37 
Linear dichroism, (393) 13 I 
Lingual von Ebner’s gland protein, (395) 95 
Link protein, (388) 211 
Lipid, (399) 87 
Lipid bilayer, (398) 12 
Lipid biosynthesis, (395) 204 
Lipid distribution, (384) 107 
Lipid monolayer, (388) 103 
Lipid peroxidation. (384) 19. 92; (386) 33 
Lipid polymorphism, (390) 133 
Lipid-associated pentides. (384) 185 
Lipid-modified sdFv, (399) 232 
Lipid-protein interaction, (386) 2 I 
Lipochitooligosaccharides, (393) 273 
Lipodepsipeptides, (381) 213 
Lipoic acid, (379) 74 
a-Lipoic acid, (394) 9 
Lipolysis, (396) 90 
Lipopolysaccharide, (386) 247: (395) 119 
Lipopolysaccharide serological specificity, (398) 297 
Lipopolysaccharide, cytokines, (390) 109 
Lipoprotein, (385) 149; (386) 197: (395) 204 
Lipoprotein receptor, (386) 197 
Liposome, (383) 155; (384) 177; (386) 243; (388) 115; (389) 111; (397) 
70 
Lipospetmine, (396) 7 1 
Lipoxygenase, (395) 148; (396) 266 
Lipoxygenase activity, regulation. (391) 238 
Liquid chromatography, mass spectrometry. (381) 77 
Liquid-crystalline dispersion, (392) 269 
Lithium, (386) 225; (399) 317 
Lithium tolerance, (387) 89 
Liver, (394) 25; (395) 77,241: (398) 193 
Liver activating protein. (39 1) 282 
Liver development. (392) 137 
Liver (rat), (379) 18 1 
Living cell, (388) 16 
LMP7 knock out mouse. (383) 109 
Localization, (394) 34 
Locally unfolded structure, (381) 237 
Locomotor activity, (385) 205 
Locus coeruleus, (390) 217 
Locus control region, (391) 282 
Lofentanil, (384) 198 
Long-PCR, (392) 30 
Long-term organ culture, (394) 51 
Long-term potentiation, (382) 48 
Loon (394) 3 11 
Loop’modeling. (399) I 
Low density lipoprotein. (389) 136: (398) 53 
Low density lipoprotein oxidation. (379) 51 
Low oxidoreduction potential, (389) 203 
Low-protein feedjng, (396) 53 
Low-spin heme B ligand, (394) 349 
Low-temperature spectroscopy, (393) 131 
Loxiglumide, (383) 241 
L-type Ca’ ‘+ channel. (378) 121; (382) 244 
Luciferase, (378) 166; (384) 83: (389) 225 
Luciferin. (395) 188 
Luciferyl adenylate, (395) 188 
Luminal protein, (399) 33 
Lung, (380) 103 
Lung mflammation, (379) 265 
Lupinus albus, (398) 159 
LuteinizingiChorionic gonadotropin receptor. (378) 27 
Lycopene, (384) 240 
Lycopersicon esculentum. (390) 275 
Lymphocyte membrane, (380) 165 
Lymphocyte proliferation, (390) 196 
Lymphotoxin (TNF-B), (386) 72 
Lyn. (399) 241 
Lysine. (385) 101; (392) 285 
L-Lysine. (386) 247 
Lysine-binding site, (387) 58 
L-a-Lysophosphatidylcholine, (398) 48 
Lysophosphatidylcholine, (391) 263; (399) 87 
Lysosomal acid lipase. (397) 79 
Lysosomal enzyme hyperactivity, (394) 307 
Lysosomal enzymes, (382) 37 
Lysosomal phospholipidosis, (394) 307 
Lysosome, (390) 47; (398) 37; (399) 13 1 
Lysozyme, (382) 186 
Lysozyme-galactomannan conjugate, (383) 251 
Lysozyme-palmitic acid conjugate. (383) 251 
Lysyl oxidase, (398) 231; (399) 215 
M intermediate decay, (386) 55 
M 1 antigens, (393) 264 
az-Macroglobulin superfamily. (393) 37 
Macromolecular crowding, (390) 245 
Macromolecules, (386) 255 
Macrophage, (382) 37; (389) 145; (390) 203; (391) 287,293; (395) 119; 
(398) 37 
Macrophaae colony-stimulating factor, (399) 207 
Macrophage migration inhibit&y factor. (381) 199; (385) 225 
Magnification factor, (392) 169 
Ma&olia, (387) 94 
Main immunogenic region, (389) 195 
Maize, (386) 75; (393) 287; (396) 147 
Major histocompatibility complex class II. (389) 55 
Major Histocompatibility complex I, (387) 42 
Malaria, (393) 189 
Malaria (Plasmodzum fulciparum). (388) 119 
Malate dehydrogenase. (382) 137 
Malate synthase, (390) 258 
Maltose, (388) 177 
Maltose-l-phosphate, (388) 177 
Mammalian DNA cytosine-5 methyltransferase. (392) 179 
Mammary gland, (380) 215: (382) 149: (389) 257; (396) 77 
Mammary gland (rat), (379) 186 
Mandatory condensation, (390) 245 
Manganese, (399) 3 17 
MAP kinase, (378) 74.207; (379) 255: (382) 89; (384) 25, 181; (388) 
180; (392) 209; (395) 133: (396) 233; (397) 89, 164 
MAPIA, (384) 147 
MAPIB, (384) 147; (388) 131 
MAP2, (384) 147 
MAPK cascade, (398) 193 
MAPKAP kinase, (392) 209 
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MAR, (380) 161 
MARCKS, (378) 281; (395) 1 
MARCKS phosphorylation. (381) 183 
Marijuana, (393) 23 1 
Masked cysteine residue. (394) 126 
Mass spectrometry, (384) 269; (390) 109; (391) 175, 317, 333: (393) 
241; (394) 201; (395) 6 
Masseter, (386) 87 
Mast cell, (379) 1; (383) 170; (390) 265,285: (392) 289 
Mathematical model, (378) 51 
Mating factor, (391) 162 
Matrix assisted laser desorption mass spectrometry, (397) 45 
Matrix-assisted laser desorption/ionization. (384) 269 
Matrix-assisted laser desorptionlionization mass spectrometry. (379) 
165 
Matrixmetalloproteinase,(380) 17; (390) 187,221; (393) 101: (397)277 
Matrix metalloproteinase 3, (381) 115. 222 
Matrix metalloproteinase 9, (383) 241; (392) 175 
Mature acid sphingomyelinase, (399) 227 
MaxiK channel, (382) 84 
Mb, myoglobin, (383) 13 
MCM6, (398) 135 
Mdjlp, (380) 142 
MDRl, (383) 99: (399) 29 
MDRZ, (399) 29 
meaB, (388) 200 
Mechanism, (383) 259 
Medicinal leech, (390) 145 
Melanocytes, (399) 175 
Melanotrope cell. (379) 165 
Melatonin, (381) 98: (386) 219 
Membrane, (384) 123; (395) 211 
Membrane anchor, (380) 133, 169 
Membrane association, (381) 63 
Membrane attack complex. (399) 272 
Membrane blotting hydrolysis, (386) 60 
Membrane channel, (381) 111: (392) 304 
Membrane epitope, (395) 29 
Membrane fusion, (388) 115; (390) 315; (391) 17 
Membrane glycolipid. (388) 29 
Membrane insertion, (390) 73 
Membrane isoenzyme, (392) 1 
Membrane leakage. (390) 1 
Membrane lipid, (382) 209 
Membrane lysis, (380) 237 
Membrane permeability, (387) 149 
Membrane permeabilization, (383) 93: (395) 48 
Membrane potential, (387) 149: (388) 34; (392) 143 
Membrane protein, (380) 296; (382)209; (384) 185; (393) 81; (396) 123. 
161; (397) 30; (399) 26.75, 307 
Membrane receptor, (394) 268 
Membrane skeleton, (383) 201 
Membrane solubilization, (390) 1 
Membrane topology, (390) 137 
Membrane trafficking, (378) 135: (392) 250 
Membrane ultrastructure. (390) 133 
Membrane vesicle, (38 1) 25 
Membrane voltage, (397) 298 
Membrane-type matrix metalloproteinase. TIMP-2. (397) 277 
Memory facilitating substance, (391) 149 
Menaquinone (vitamin K2) biosynthesis, (378) 13 1 
menF, (378) 131 
Mesangial cell, (382) 271; (396) 67 
Mesangial cell (rat kidney). (394) 263 
Mesembryanthemum crystallinum L., (389) 314 
Message stability, (394) 285 
Messenger RNA, (387) 157: (388) 155 
M/%4, (387) 179 
Metabolic degradation, (379) 227 
Metabolic labeling. (387) 109 
Metabolic salvage process, (391) 336 
Metabolic zonation, (388) 228 
Metabolism, (384) 123 
Metabolism regulation, (389) 15 
Metabotropic, (392) 71 
Metal binding, (398) 175 
Metal binding center, (392) 91 
Metal chelation, (380) 209 
Metal chelator. (392) 40 
Metal coordination, (396) 248 
Metal intoxication, (380) 33 
Metal-catalyzed oxidation, (396) 95 
Metallo-enzyme, (392) 81 
Metallopeptidase, (381) 188 
Metalloprotease. (381) 42 
Metalloproteinase, (382) 285; (384) 155; (385) 238 
Metallothionein, (380) 33; (386) 1; (389) 210 
Metastable state, (383) 87 
Metastasis, (380) 21 
Met-enkephalin, (383) 230 
Methunobacterium bryantii, (383) 245 
Methanobacterium thermoautotrophicum, (399) 171 
Methanogen, (399) 171 
Methanol, (390) 199 
Methanopyrus, (379) 127 
Methanothermus fervidus, (383) 245 
Methunothermus sociabilis, (392) 148 
Methionine biosynthesis, (379) 94 
Methionine sulfoxide. (391) 323 
Methyl jasmonate, (383) 83 
2’-O-Methyl RNA, (384) 207 
3-Methyladenine, (397) 127 
3-Methyladenine DNA glycosylase. (397) 127 
Methylation. (380) 103 
P-Methylcrotonyl-CoA carboxylase, (383) 175 
Methylmalonyl-CoA mutase, (394) 126 
Methylotrophic yeast, (394) 268 
Mevalonate synthesis, (379) 43 
Mg2+, (395) 241 
Mg*+ coordination, (38 1) 106 
Mg2+ dependence (386) 99 
Mgz+ effect (394)‘335 
Mg*+ ion, (!+92) 205 
MG-63 cell, (396) 103 
mGCM 1, (393) 20 1 
MGFBTATS, (389) 257 
MHC affinity. (387) 42 
MHC class I, (383) 119 
MHR peptide. (378) 43 
Micrococcus luteus, (384) 107 
Microfibrils, (386) 169 
Microfilament regulation, (399) 103 
Microfilaments, (388) 131 
Microinjection, (394) 227, 233 
Micropreparation, (397) 45 
Microsatellite, (389) 92 
Microscopy, (389) 238 
Microsequencing, (399) 33 
Microsome, (387) 171; (395) 39 
Microtubule, (379) 191; (380)63; (384) 147; (385) 7; (387) 145; ( 
Microtubule-associated protein. (379) 222; (399) 344 
Microtubule-associated protein 2, (388) 76 
Microtubule-associated protein (MAP). (379) 191 
Microvilli, (395) 137 
Micrurus, (380) 29 
1394) 34 
Midbra& (393) 139 
Migration. (380) 21 
Milk protein, (383) 18 
Milk protein gene expression, (389) 257 
Mimosine, (380) 209 
Mineralocorticoid receptor, (384) 112 
Minizyme. (386) 99 
Misincorporation. (391) 113 
Mistletoe, (396) 261 
Mistletoe lectin I, (392) 166; (399) 153 
Mithramycin, (380) 118 
Mitochondria-associated membranes. (395) 262 
Mitochondrial Ca’+. (379) 305 
Mitochondrial Ca2+ uptake, (393) 135 
Mitochondrial depolarization. (397) 230 
Mitochondrial fatty acid oxidation, (390) 1 
Mitochondrial Hsp70 system, (380) 142 
Mitochondrial import, (378) 182; (384) 38 
Mitochondrial membrane. (379) 305 
Mitochondrial permeability transition pore, (378) 150 
86 
Mitochondrial porin, (396) 189 
Mitochondrial presequence, (388) 34 
Mitochondrial protein import, (391) 203 
Mitochondrial protein phosphorylation. (379) 299 
Mitochondrial respiratory chain, (387) 7 
Mitochondrial transmembrane potential. (384) 53 
Mitochondrion(378) 107; (38Oj169; (381)42,123: (382)31.153; (384) 
9;(390)39,73;(391)323,330;(392)54. 143;(393)86;(394,321; 
(395) 119; (396)7, 181,276,279; (397) 7; (398)248: (399) 87.95.299 
Mitochondrion (kidney), (379) 305 
Mitochondrion (rat liver), (389) 233 
Mitogen, (392) 125 
Mitogen-activated protein kinase. (383) 273: (385) 149: (389) 2X5: 
(394)34: (396)103 
Mitosis, (389) 66 
Mitoxantrone, (379) 269 
MMP, (378) I26 
MMP-9. (382) 285 
MMTV uromoter. (389) 244 
Mn cluster, (387) 33 
Mn(III) porphyrins. (381) 82 
MoaA, (391) IO1 
Model membrane. (397) 70 
Model organism, (396) 1 
Modification, (382) 164 
Modified nucleotide. (395) 283 
Modified oligonucleotides. (378) 224 
Modulation, (384) I89 
Modulator, (387) 184 
Modules, (391) 229 
Molecular assembly. (388) I03 
Molecular chaperone. (380) 152; (397) 283 
Molecular cloning, (399) I98 
Molecular complex, (39 I ) I53 
Molecular conformation. (398) 291 
Molecular dvnamics. (386) 65: (398) 87: (399) 9 
Molecular &olution, (385) 214;‘(392) 63:‘(397) 143 
Molecular factor of virulence. (382) 79 
Molecular heterogeneity, (394) I 
Molecular interaction. (390) 161; (391) 153: (398) 291 
Molecular mechanism. (390) I04 
Molecular modeling. (385) 105; (392) 105: (395) 99: (399) 75 
Molecular parasitology, (389) 80 
Molecular recognition, (380) 219: (385) 81 
Molecular switch protein, (380) 233 
Mollusc. (382) 93 
Molybdopterin cofactor, (39 I ) 10 I 
MO-MuLV. (392) 229 
Mono ADP-ribosyl transferase. (382) 276 
Monoamine, (395) 153 
Monoclonalantibody.(380)29: (381) 119: (385) 11;(386)72:(387) 16: 
(388)99;(389)195,297;(391)52.209;(393)297:(395),45 
Monocyte, (398) I ; (399) 321 
Monocyte chemoattractant protein-l, (394) 137 
Monocyte chemotactic protein. (395) 277 
Monocyte (human), (388) I I9 
Monocyte-derived macrophage. (396) I57 
Monocyte-macrophage (human). (388) I65 
Monofunctional glycosyltransferase. (392) I X4 
Monolayer insertion, (388) 34 
Monomer-dimer. (395) 277 
Mononuclear celL‘(399) 321 
Monte Carlo simulation. (387) I I 
Morphine dependence, (391) I I 
Mossbauer spectroscopy, (38 I ) 53 
Motility, (383) 55 
Motilitv assay (in vitro). (380) I3 
Motility (in vitro), (380) 281 
Motion, (392) 169 
Mouse. (381) 165; (393) 139. 307 
Mouse brain, (383) 219: (395) 123 
Mouse cerebellum, (391) 1 I 
Mouse colliculi 5-HTj receptor, (398) I9 
Mouse embryogenesis, (394) 103 
Mouse fibroblast, (389) 115: (390) I91 
Mouse hemopoietic cell line, (391) 104 
Mouse hepatocyte, (388) I73 
Mouse kidney. (393) I67 
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Mouse liver, (38 I ) 39 
Mouse Notch receptor. (395) 221 
Movement protein, (397) 75 
Mpl. (395) 228 
MRF4, (390) 304 
mRNA, (379) 55: (384) 78; (386) 87; (393) 19, 307; (394) 247.285 
mRNA differential display. (378) 219; (382) 48 
mRNA editing, (391) 57; (393) 253 
mRNA export. (396) 47 
mRNA expression, (381) 135 
mRNA replication. (390) I24 
mRNA sequence, (399) 78 
mRN.4 transfection, (380) 108 
MRP, (383) 99 
MTI-MMP, (393) 101 
M-type K’ current. (384) 277 
Mu opioid receptor. (387) 53 
Mucin glycoprotein, (378) 2 13 
Multidomain enzyme, (380) I57 
Multidrug resistance, (391) 61. 126: (394) 129: (399) 317 
Multifunctional enzyme, (379) 97 
Multigenic family, (394) 258 
Multiple forms. (382) 164 
Multiple promoters, (394) 371 
Multiple sequence alignment. (397) 225 
Multiubiquitin chain binding subunit, (381) 143 
MurE. (391) I71 
Murine erythroleukemia cell differentiation, (386) 95 
Muscarinic receptor. (386) 51 
Muscle. (386) 87; (395) 211 
Muscle contraction, (380) 28 I 
Muscle elasticity, (385) I I 
Muscular dystrophy, (384) I : (393) 292 
Mutagenesis, (394) 196: (395) 22. 199: (397) 301; (398) 322: (399) 193 
Mutant. (385) 209. (391) 257 
Mutants of CK2. (380) 25 
Mutation. (384) I89 
Mutation rate, (390) 99 
Mutational analysis. (387) 63 
Myasthenia gravis, (389) 195 
myh gene. (379) I17 
,~w1huctrriun7 tuhrrcu/osrs. (387) I05 
Myeloid leukemia, (394) 356 
Myeloperoxidase, (379) 103 
Myocardial ischemia. (390) I 
Myocardium. (378) I I I: (394) 99 
Myocyte. (382) 31 
Myogenic differentiation. (387) 117; (397) 219 
Myogenin, (390) 304 
Myosin, (386) 87; (391) 39 
Myosin ATPase. (380) I? 
Myosin heavy chain, (399) 220 
Myosin Sl binding, (384) 43 
Myotonia. (396) I77 
Myrosinase inhibitor. (3851 87 
“N labelling, (385) 114 
Na. absorption, (381) 47 
Na- pump, (381) 174 
Na U’ansDort. (388) 217 
Na’ ,K+-ATPase, (3X0) 277; (390) 323; (396) 309 
Na+/Cll/taurine cotransporter regulation. (392) 250 
Nat /Li+ selectivity, (38X) 217 
Na’ -Ca’- exchanger, (397) 298 
Na+-translocating NADH-quinone reductase, (381) 174 
Na,K-ATPase, (389) 179; (395) 29 
N-acetylcysteine, (394) 9 
cr3/p4 nAChR, (397) 39 
NaCI-free medium (37X) 27 
’ NAD, (387) 85 
NAD metabolism, (399) 3 I3 
NAD-. (379) 236; (396) 327 
NAD--dependent formate dehydrogenase. (390) 104 
NADH, (393) 317 
NADH dehydrogenase. (378) 277 
NADH-ubiquinone oxidoreductase, (379) 299 
NAD(P)‘. (399) 92 
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NADPH oxidase. (380) 263: (381) 156; (382) 213; (383) 181: (385) 229 
NADP-malate dehydrogenase, (392) 121 
Narcotic dependence and tolerance, (387) 53 
Nascent chain, (390) 249 
Nascent peptide, (378) 166 
Nascent polypeptide chain, (385) 67 
Native glucotropaeolin, (385) 87 
Native elvcoorotein. (384) 23 1 
Naturaton, {381) 11 L ’ 
Nb2 cell bioassav. (387) 167 
ndh gene, (378) 277‘ 
NDHI, (393) 81 
NDHZ, (393) 81 
NDP kinase, (399) 183 
Nebulin, (397) 136 
Necrosis, (384) 61; (390) 91; (396) 337 
Nef, (393) 93, 105; (395) 257 
Negative DNA supercoil, (384) 265 
Negative growth factor, (378) 61 
Neopterin, (391) 18 1; (397) 263 
Neprilysin, (380) 79 
Nerve growth factor, (379) 77. 157; (394) 117 
Nerve terminal, (398) 211 
Neuroblastoma, (381) 131; (384) 78; (397) 325 
Neuroblastoma X elioma hvbrid cell. (379) 236 
Neuroblastoma cell (394) lj4 
Neurodegenerative disease, (383) 219; (399) 75 
Neurofibromatosis type 1 (NFI), (382) 53 
Neurotibromin, (382) 53 
Neurogenesis, (393) 201 
Neurokinin A, (399) 264 
Neuromuscular‘junction, (398) 259 
Neuron, (379) 239; (383) 59; (394) 321 
Neuronal Ca2+ overload, (397) 230 
Neuronal Cdk5 activator (nck5a), (378) 48 
Neuronal differentiation, (381) 93; (385) 131 
Neuronal nuclei, (383) 6 
Neuronal protein, (390) 21 
Neuropathology, (394) 17 
Neuropeptide, (378) 83: (399) 264 
Neuropeptide Y. (380) 237; (394) 169 
Neurosoora crassa. (3781 32 
Neuroioxicity, (392) 143 
Neurotoxin, (380) 29; (386) 133. 137 
Neurotransmission, (385) 119 
Neurotransmitter, (395) I53 
Neurotransmitter transporter, (386) 189 
Neurotrophic peptide, (396) 143 
Neutral endopeptidase, (380) 79 
Neutral serine protease, (390) 265 
NeutrophiL(379) 103; (380) 198; (383) 181: (386)239: (393) 117; (395) 
293 
Neutrophil elastase, (390) 187 
Neutrophil eranulocvte, (38 1) 156 
New exon, (388) 76 . 
NF-aB, (379) 265,279; (380)224: (385) 58; (389) 119; (392) 129; (393) 
69: (397) 108 
NFlcB activation, (394) 263 
NGF receptor, (383) 255 
NH,CI, (398) 61 
Nickel. (383) 79; (392) 81 
Nicotiana tabacum. (386) 5 
Nicotinamide, (380) 188; (394) 61 
Nicotinic receptor. (399) 83 
Nisin. (390) 129 
Nitrapyrin~ (397) 35 
Nitrate assimilation. (393) 7 
Nitrate reductase, (387) 127: (392) I ; (398) 26 
Nitrate respiration. (392) I 
Nitric oxide, (378) 107; (379) 7,74,286; (380)49; (381) 21. 82; (382) 
223: (383) 42: (384) 162; (385) 4,63; (389) 149; (391) 21, 181. 185; 
(392) 274; (394) 300; (395) 299; (396) 67,315: (397) 263; (398) 53 
Nitric oxide synthase, (379) 82,279: (380) 224; (381) 82; (392) 242; 
(395) 119.299; (398) 159 
Nitric oxide svnthase repression, (394) 5 I 
Nitrification,i397) 35 
Nitrite, (390) 203 
Nitrite reductase. (394) 87 
Nitrogen dioxrde, (389) 13 I 
Nitrogen fixation. (393) 273; (394) 153 
Nitrogen metabolite repression. (388) 200 
Nitrogen regulation, (391) 223 
Nitrogenase (Azotobacter vinelandii), (380) 233 
&Nitroguanine, (399) 67 
?Nitrosofluorene, (389) 233 
S-Nitroso-glutathione, (389) 149 
Nitrosomonus europea, (397) 35 
S-Nitrosothiol. (378) 111 
Nitrosothiol, (382) 223 
S-Nitrosylation, (392) 274 
Nitrosylmyoglobin, (378) 111 
Nitrotyrosine, (379) 74,286; (385) 63; (392) 293 
Nitrous oxide, (382) 223 
N-linked glycosylation site. (389) 289 
NLS-receptor, (389) 75 
nm23, (399) 183 
NMDA. (379) 82 
NMDA activation, (394) 141 
NMR. (378) 43: (381) 119,237: (382) 249; (383) 191; (384) 155: (385) 
15,91, 114; (387) 201; (388) 66, 177; (391) 302,317; (392) 295,309; 
(393) 280: (394) 169; (395) 160,277: (399) 163, 166, 303 
NMR assignment, (399) 283 
NMR spectroscopy, (378) 79 
NMR structure, (391) 203 
NMR. ‘H-. (383) 31 
NMR, H-bonding interaction (399) 43 
NO svnthase, (390) 203 
Nociceptin, (395) 207 
Nociceptin/orphanin FQ, (395) 17 
Nodulation, (393) 273 
Nodulation factor, (388) 66: (393) 273 
Nogalamycin. (380) 118 
Non-allosteric property. (392) 148 
Non-covalent binding, (396) 108 
Non-covalent interaction, (384) 269 
Non-electrostatic force. (398) 279 
Non-genomic action, (396) 157 
Non-heme iron, (381) 53; (385) 138 
Non-insulin-dependent diabetes mellitus, (379) 203 
Nonlinear dynamics, (390) 229 
Non-linear regression, (392) 245 
Non-LTR element, (380) 1 
Non-NMDA receptor, (390) 157 
Nonpeptide antagonists. (394) 361 
Non:productive t%lding form. (393) 15 I 
Non-selective cGMP-gated cation channel. (389) 213 
Non-specific cross-reacting antigen, (385) 72 
Nonspecific intercalation. (399) 267 
Non-structural protein, (378) 37 
Noradrenaline, (385) 176; (391) 189 
Noradrenergic phenotype, (385) 159 
Normal phase HPLC. (381) 77 
Northern analysis, (391) 269: (395) 95 
Northern blot, (398) 253 
nqr operon, (381) 174 
NT3, (379) 247 
N-terminal deblockine. (390) 199 
N-terminal domain, (398) 43 
N-terminal processing, (390) 109 
N-terminal sequence, (399) 227 
ntr svstem. (388) 53 
Nuclear calcium, (387) 85 
Nuclear export. (394) 233 
Nuclear factor 1, (390) 44 
Nuclear factor rB, (382) 323; (385) 4, 109; (391) 181; (394) 9 
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Protein solubility, (382) 21 
Protein sorting, (382) I53 
Protein stabilzy, (380) 152 
Protein stabilization. (388) 21 
Protein stretching, (385) 29 
Protein structure, (379) 85; (393) 241 
Protein structure comparison, (391) 167 
Protein structure prediction, (397) 225 
Protein synthesis, (391) 330; (397) 55: (399) 59 
Protein targeting, (399) 307 
Protein translocation, (381) 25; (389) 281: (390) 175 
Protein turnover, (389) 314; (393) 292 
Protein tyrosine kinase, (395) 286 
Protein tyrosine phosphatase, (378) 7; (391) 219 
Protein tyrosine phosphatase lC, (383) 165 
Protein unfolding, (385) 29 
Proteinase 3. (382) 130: (390) 265 
Proteinase inhibitor, (383) 159; (390) 275; (393) 37 
a-1-Proteinase inhibitor, (390) 187 
at-Proteinase inhibitor-immunoglobulin A complex. (385) 201 
Protein-DNA interaction, (381) 106; (391) 79 
Protein-ligand docking and design, (384) 87 
Protein-nucleic acid interaction, (392) 105 
Protein-protein interaction, (379) 122; (380) 219; (382) 18; (383) 124; 
(384) 1.61; (388) 5: (391) 79; (392) 179 
. ’ Protein-tyrosine kinase, (389) 285 
Proteoglycan, (381) 222; (396) 127 
Proteoelvcan tandem reueat. (388) 211 
Proteo&osomes, (388) i28;‘(391)134’ 
Proteolysis, (378) 177; (379) 191; (385) 67; (386) 82; (388) 21; (389) 32, 
297; (390) 129; (391) 229; (392) 11.293 
Proteolvtic cascade. (393) 31 
Proteolytic degradation, (385) 63 
Proteolytic protection assay. (379) 207 
Proteus mirabilis, (386) 247; (398) 297 
Prothymosin a, (397) 2 15 
Protochlorophyllide reductase, (398) 235 
Proton channel mutant, (393) 155 
Proton gradient, (379) 309 
Proton motive force, (38 1) 25 
Proton movement, (398) 333 
Proton pump, (388) 47 
Proton pumping, (391) 134 
Proton transfer, (385) 53; (393) 221 
Proton translocation, (379) 309; (382) 121 
Proton transport, (387) 122; (399) 251 
Protonated Schiff base, (398) 239 
Proton-coupled peptide transporter, (394) 196 
Proto-oncogene product Cbl, (397) 113 
Proto-oncogene protein, (394) 356 
Protopectinase, (398) 269 
Protoplast, (380) 97 
PrP, (389) 3 
psbX, (390) 175 
Pseudoazurin, (394) 87 
92 
Pseudoknot structure (394) 132 
Pseudomonas aeruginosa. (396) 213.243 
Pseudumonasfuscovaginae. (38 1) 2 13 
Pseudopodium. (382) 193 
Psoriasis, (378) 88 
pssA. (395) 262 
PstC. (394) 206 
PstS, (394) 206 
pSV2CAT DNA. (397) 207 
P-type ATPase. (399) 143 
PUFA. polyunsaturated fatty acids. (380) 204 
Pulmonary smooth muscle tissue, (387) 171 
Pulmonaj surfactant, (384) 185 
Pulsed field gel electrophoresis, (396) 337 
Pura, (391) 11 
Purification, (381) 169; (383) 227; (384) 215: (394) 55; (399) 143 
Purification (Brad?;rhi~ohiumjaporlicum), (392) I 
Purine receptor, (388) 123 
Purinoceptor, (378) 1: (384) 260 
Purkinje fibers. (380) 39 
Purplemembrane, (387) 122; (399) 251 
Putrescine, (385) 189 
Pvcno~orus cinnabarinus. (391) 144 
Pyoverdin, (396) 243 
N-( l-Pyrenyl)maleimide, (392) 54 
Pyridine nucleotide, (397) 93 
Pyridinoline, (388) I34 
Pyridoxal5’-phosphate, (379) 94; (389) 12: (390) 85; (398) 141 
Pyridoxal phosphate, (389) 263: (390) 179 
Pwococcus, (394) 66 
Pyrococcu.~ woesei, (383) 245 
Pyrroloquinoline quinone. (393) 3 I? 
Pyruvate, (380) 287 
Pyruvate dehydrogenase. (394) 96 
Pyruvate dehydrogenase kinase, (393) 174 
Pyruvate inhibition, (393) 174 
Pyruvate kinase, (389) 15 
Pyruvate,orthophosphate dikinase. (396) 152 
Q-cycle, (387) 1 
Quantitative analysis, (379) 222 
Quantitative reverse transcription polymerase chain reaction. (394) 39 
Quantitative RT-PCR, (390) 157: (396) 177 
Quaternarv comolex. (399) 59 
Quaternaj structure. ‘(383) 245; (394) 44, 3 16 
Quinol oxidase. (399) 21 
Quinone reductase, (389) 25 
R region, (392) 220 
rab3, (391) 263 
Rabbit liver, (382) 18 
Rabbit muscle, (398) 3 17 
Rat, (399) 211 
Racemase, (388) 80 
RAC-protein kinase, (396) 305 
Radiation damping. (383) 191 
Radical anion, (389) 20 
Radical cation, (384) 240 
Radical oxygen intermediate. (392) 129 
Radical scavenger, (384) 240 
Radioactive gangliosides, (39 I ) 336 
y-Radiolysis, (392) 45 
Raf. (378) 15 
rag 2; (385) 7 
Ragi bifunctional inhibitor, (397) 1 1 
Rainbow trout, (382) 261: (389) 244 
Raman spectroscopy. (382) 26: (396) 248 
Ran. (389) 75 
Random mutagenesis, (387) 179; (399) 313 
Random phage library. (399) 237 
Random protein, (382) 21 
RANTES, (398) 223, 308 
Rare earth ion, (393) 97 
Ras, (378) 15: (380) 113; (397) 89 
Ras gene, (383) 150 
Ras protein, (391) 310 
Ras-based inhibitor, (391) 310 
rasGAP homologue, (394) 25 1 
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Ras-processing peptidase. (391) 310 
Rat.(381) 12;(382) 125; (388) 134:(389)309:(390)311;(394)44,371: 
(395) 293: (399) 220 
Rat adrenal gland, (385) 159 
Rat brain. (383) 26; (391) 232; (393) 89; (396) 139 
Rat cardiomyocyte, (379) 255 
Rat cerebellum. (390) 207 
Rat cultured hepatocyte. (399) 310 
Rat development, (391) 57 
Rat F antigen, (393) 269 
Rat heart, (393) 174 
Rat heart mitochondria, (397) 260 
Rat hepatoma, (394) 55 
Rat hippocampus, (393) 303 
Rat intestine. (394) 196 
Rat kidney cortex, (396) 309 
Rat liver, (381) 169; (386) 33; (389) 225; (390) 258 
Rat liver mitochondria. (382) 256; (386) 255: (389) 293 
Rat mast cell protease I, (383) 170 
Rat mesangial cells, (397) 108 
Rat T lymphocyte alloantigen. (388) 189 
Rat testis, (388) 21 
Rat thymocytes, (391) 35 
Rate constant. (398) 179 
Rational drug design, (394) 191 
RAW 264 mouse macrophage. (391) 287 
RB gene promoter, (397) 2 19 
R-binding protein, (382) 93 
RBL-I cells, (390) 285 
RBL-2H3 cells, (398) 67 
RCA]. (381) 42 
RCAZ. (388) 185 
RCS rat, (387) 63 
rd chicken, (385) 47 
rDNA, (388) 192 
Reaction center, (383) 129: (385) 209; (393) 131; (396) 161 
Reaction center protein, (385) 193: (395) 251 
Reaction mechanism. (382) 249; (393) 97 
Reactivating kinase, (395) 133 
Reactive center loop, (383) 87 
Reactive nitrogen species, (381) 21 
Reactive oxygen. (378) 107; (391) 35 
Reactive oxygen intermediate, (394) 9: (397) 263 
Reactive oxygen species, (378) 150: (379) 286: (381) 21; (388) 161; 
(397) 7: (398) 223 
Receptor,(378j253;(379)77;(382) 125: (387)75:(389)61:(392)59,71 
Receptor binding, (380) 39; (385) 181; (394) 169 
Receptor dephosphorylation. (391) 219 
Receptor for AGE (RAGE). (384) 103 
Receptor phosphorylation. (387) 53 
Receptor-mediated endocytosis. (389) 48 
Recognition, (392) 169 
Recombinant cytochrome P450 (human), (397) 210 
Recombinant expression, (379) 135 
Recombinant insulin, (378) 171 
Recombinant prohormone. (382) 6 
Recombinant protein, (378) 69; (387) 36; (392) 259; (393) 205; (394) 
217; (395) 95; (396) 127; (397) 169 
Reconstitution, (380) 277.296; (382) 203. 213; (398) 12 
Reconstitution experiments. (394) 183 
Recoverin. (384) 227 
Red cell. (390) 25 
Redox. (385) 58; (387) 161 
Redox balance, (390) I53 
Redox mediator, (391) 144 
Redox potential. (385) 105 
Redox reaction, (381) 140; (385) 53 
Redox regulation, (391) 35 
Reduced flavin, (388) 242 
Reducing reagent, (392) 54 
Refolding, (382) 285; (392) 304 
Regional distribution. (379) 222 
Regiospecificity, (388) 112 
Regulated secretion, (379) 15 
Regulation, (380) 277 
Regulatory phosphorylation site. (398) 26 
Regulatory subunit, (382) 93 
Regulatory volume decrease, (395) 133 
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Renal mitochondrial la-hydroxylation. (390) 10 
Replicon. (379) 26 
Repolarization. (389) 167 
Resistance, (379) 26 
Resolution. (381) 161 
Resonance mirror analysis, (384) 138 
Resonance Raman spectroscopy. (380) 183; (396) 289 
Respiration, (398) 248 
Respiratory chain, (388) 185; (393) 8 I 
Respiratory complex assembly. (382) I I I 
Respiratory control, (391) 134; (393) I55 
Respiratory inhibitor. (398) 155 
Respiratory syncytial virus, (390) 327 
Response region, (380) 204 
Resting season, (398) 285 
Restramed molecular dynamics. (387) 301 
Restriction endonuclease. (390) 307 
Restriction enzyme, (381) iO6 
Restriction fragment length polymorphisms. (383) 150 
Reticulocyte. (389) 210 
Retina, (378) 245: (379) 82: (389) 213 
Retina development, (393) 259 
Retinal pigment epithelium. (378) 245 
Retinal ;od outer segment membrane. (389) 186 
Retinoblastoma, (399) 158 
Retinoblastoma protein, (385) 143 
Retinoic acid, (381) 93; (391) 95: (397) 22 
Retrotransposon. (380) I 
Retrovirus. (396) 47 
Reverse transcriptase, (380) 1: (391) 257: (396) 43 
Reverse transcriptase inhibitor. (389) 1 I5 
Reverse transcription, (387) 189 
Reverse transcription-polymerasechain reaction. (381) 199; (385) 225: 
(399) 122 
Reversible radical pair model. (397) 131 
Rex-responsive element, (396) 47 
RFLP mapping. (395) 58 
RGD, (384) 247 
RGD loop, (391) 139 
RGL, (380) 1 I3 
L-Rhamnulose I-phosphate aldolase, (392) 28 I 
Rheumatoid arthritis, (385) 201; (388) 161 
Rhinovirus. (396) 14 
Rhizohium. (398) I59 
Rhizohium frrdii. (393) 273 
Rho. (399) 2 I I 
Rho GTPase. (392) I89 
RhoA, (385) 221; (387) 141 
Rhodohacter. (389) 126 
Rhodohartrr &s&tu.s cytochrome (‘>. (380) 44 
Rhodopxudomonas hlastica. (38 I ) I I I 
Rhodopsin, (384) 227 
Rhodopsin kinase, (384) 227 
Ribonuclease, (382) 319; (384) 143; (392) 105: (398) 57 
Ribonuclease A, (380) 179 
Ribonucledse P, (382) 60 
Ribonuclease specificity. (399) 163 
Ribonucleotide reductase. (382) 145: (387) 137 
Ribosomal protein. (386) 260: (394) 71 
Ribosomal RNA genes. (388) 192 
Ribosome, (379) 291: (385) 67, 114; (386) 60: (389) 32: (399) 223 
Ribosome-inactivating protein (382) 309: (392) 16; (396) 57, 132: 
(399)153. 163 
Ribotoxin. (386) 60; (392) 259 
Ribozyme. (382) 116: (392) 215; (393) 97: (394) 5 
o-Ribulose 1,5-bisphosphate carboxylaseioxygenase. (392) 28 I 
Ribulose-1,5-bisphosphate carboxylaseioxygenase activase. (384) 167 
Ribulose-1.5-bisphosphate carboxylase/oxygenase activity, (388) 223 
Rice allergen, (391) 341 
Rice glutelin gene, (383) 213 
Rice leaf, (384) 167 
Ricin, (392) 166 
RID, (380) I 13 
Rieske. (388) 43 
Rieske protein. (385) 197 
RIN cell, (391) 185 
RING finger protein, (386) 103 
RlNmSF cells, (387) 47: (391) 189 
RIl\imSF microinjection. (380) 137 
RNA, (385) 15; (387) 189; (399) 344 
RNA bindine, (388) 206; (397) 75; (398) 201 
RNA editing. (381) 123 
RNA expression. (385) I 
RNA hehcase, (388) 206 
RN.4 polymerase I, (388) 192 
RN.4 polymerase II, (384) 48 
RNA processing, (387) 152 
RN.4 secondarv structure. (392) 114 
RNA splicing, (393) 113 ’ ’ 
RNA structure. (383) 185: (394) 71 
RNA vector delivery’system, (397) 143 
RNA-binding domain, (387) 152 
RNA-protein interaction (394) 71; (397) 143 
RNase A. (398) 57 
RNase L inhibitor, (381) 135 
RNAse protection assay. (397) 331 
RNase Sa. (384) 143 
rnpB gene. (386) 103 
RNPmotif. (398) 201 
Rod-like structure, (396) 177 
ROMK channel, (399) 122 
Root. (398) 159 
Root nodule. (398) 159 
Root specificity, (398) 243 
Rotational symmetry. (398) 274 
Rotenone sensitivity, (380) 176 
rRNA processing. (379) 2 12 
RS43, (390) 207 
RT6, (382) 276 
RTG-2 cell, (382) 261 
RT-PCR, (378) 145; (384) 78: (388) 150: (390) 165: (395) 95, 123 
Rubidium uptake. (396) 309 
Rubredoxin, (385) 138 
Rubriviwr &atinosus, (385) 209 
Runoff transcription (388) 53 
Ryanodine, (395) 39 
Ryanodine receptor, (380) 49, 267; (394) 76: (395) 123 
Ryanodine receptor isoform. (383) 59 
20s proteasome. (383) 109 
20s proteasome activator. (394) I83 
I IS regulator, (394) 183 
5s ribosomal RNA. (394) 71 
5s RNA. (386) 260 
4.5s RNA (E. co/i). (392) II4 
5s rRNA. (385) 114 
2s storage albumin. (385) 154 
S. curevisiur, (386) 235 
CIS l-casein, (389) 257 
S6 kinase. (399) 333 
IO.% RNA, (399) 223 
Saccharide activation, (391) I57 
.Succharom~crs cerecisiac,(380) 127, 142, 169; (381) 103; (382)89, 97, 
111;(384)38;(385)7: (387)89;(388)5. 185;(389)70,174;(390) 
137;(391) 252;(392)194;(393)236;(395)109, 199.225:(397)215; 
(398)113.303:(399)29.317 
S-adenosylmethionine: (390) 85 
S-adenosylmethionine synthetase, (397) 293 
Salbutamol. (382) 271 
Salicvlic acid. (397) 239 
Salivary gland, (393) 57 
Salivary prohne-rich protein. (382) 289 
Salt stress. (382) 89 
Sam68.(389)141 
SAP-l, (391) 247 
Saporin 6. (392) 16 
Saposin B, (393) 74 
SAR, (380) 161 
a-Sarcin. (399) 163 
y-Sarcoglycan. (381) 15 
Sarcoglycan complex, (381) I5 
Sarcolemma. (394) 99 
Sarcoplasmic calcium-binding protein. (395) 89 
Sarcoplasmic or endoplasmic reticulum calcium ATPase. (396) 115 
94 
Sarcoplasmic reticulum, (380)49,267; (386) 205; (388) 128; (392) 274; 
(396) 115 
Satellite DNA, (394) 187; (395) 11 
Saturated fatty acid, (394) 149 
Scanning calorimetry, (393) 15 1 
Scanning force microscopy. (382) 65: (397) 30 
Scanning process, (392) 169 
Scavenger receptor, (399) 241 
ScgR, (389) 28 I 
Srhi;osaccharonlycespornbr. (378) 185: (379) 217; (381) 127: (395) 272 
SCID, severe combined immunodeliciency. (384) 1 
Scorpion, (384) 277 
Scorpion toxin, (390) 8 1 
Scrapie, (389) 3 
Sea urchin, (378) 115 
Sea urchin egg homogenate. (379) 227 
Seasonal acclimatization, (399) 290 
SecG, (381) 25; (389) 281 
Second messenger, (379) 236 
Secondarystructure,(378)43,190; (379)291; (384) 185; (388)66; (391) 
302; (396) 248; (399) 283 
Secondary structure prediction, (383) 87; (388) 211 
Secretion, (383) 255; (386) 137; (392) 259; (393) 185; (394) 109 
Secretogranin. (379) 273 
Secretogranin II, (394) 295 
Secretoneurin, (394) 295 
Secretory expression, (387) 167 
Secretory vesicle, (39 I) 269 
Seed. (396) 285 
Seed development. (379) 117 
Seed storage protein. (387) 94 
Seizure, (382 j 48 
Selectin, (380) 165 
Selective binding, (394) 289 
Selenium, (387) 157 
Selenomethionyl protein, (384) 219 
Selenoorganic compound. (398) I79 
Self replicating recombinant mRNA. (380) 108 
Self-association. (384) 61 
Seminal plasma, (382) 319 
Seminal ribonuclease, (398) 326 
Sendai, (391) 17 
Senescence. (389) 115 
Sensor orotein. (393) 7 
Sensory rhodop& (395) I95 
Septide, (399) 264 
Septum organization. (392) 237 
cis Seauence. (397) 97 
Sequence, (384) 9:(387) 189; (388) 43; (390) 39 
Sequence analysis, (397) 25 
Sequence context, (391) 113 
Sequence homology. (389) 289 
Sequence periodicity, (393) 65 
Sequence-specific NMR assignment, (379) 29 1 
Sequence-structure relationship. (379) 148: (399) 78 
Sequential assignment, (391) 302 
SER spectroscopy, (397) 61 
Serine enzyme, (392) 117 
Serine protease, (380) 79; (386) 47: (398) 146. 187 
Serine protease family, (397) 83 
Serine protein kinase, (399) 326 
Serine proteinase, (378) 37; (394) 165; (397) 1 I 
Serine proteinase inhibitor. (385) 165 
Serinelthreonine kinases. (384) 1 
Serine/threonine orotein kinase. (385) 221 
Serotonin biosynihesis, (392) 2@ 
Serotonin release, (385) 176 
Serotonin transporter, (394) 44 
Serpin, (383) 87 
Serprocidin, (398) 146 
SERRS spectroscopy. (396) 196 
Serum albumin, (378) 190 
Serum depletion, (399) 71 
Serum immunoglobulin, (378) 153 
Serum responsive element, (39 1) 247 
Serum responsive factor. (391) 247 
Severe childhood autosomal muscular dystrophy, (381) 15 
Sexual differentiation, (378) 207 
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SII2domain. (381) 191: (390) 170 
SH3 domain. (379) 244; (385) 229: (389) 141: (399) 326 
She, (378) 74 
Sheep hydatid cyst glycoprotein, (398) 183 
P-Sheet. (390) 249 
Shock, (381) 82 
Shotgun sequencing. (396) 1 
Sialic acid, (385) 197; (388) 29; (395) 170 
Sialyl-Lewis”, (399) 203 
3’-Sialyl-hi-acetyllactosamine. (399) 203 
Sialyltransferase, (383) 223 
Signal amplification, (394) 61 
Signal peptidase, (398) 198 
Signal peptide, (390) 294 
Signal recognition particle, (384) 219: (399) 307 
Signal recognition particle (SRP), (384) 215 
Signal sequence, (387) 23. 167; (392) 259 
Signal transduction, (378) 83.88.207: (379) 236; (380) 219; (382) 89, 
293; (389) 61: (390) 78; (391) 131. 333; (392) 189; (393) 161; (394) 
221,237; (395) 195,228; (396) 77.233: (398) 193 
Signaling, (393) 236: (394) 365 
Signaling pathway, (385) 13 I 
S-II, (385) 21 
SII-Tl, (385) 21 
SNl. (382) 97 
SINlISPT2, (388) 5 
Single chain antibody. (396) I4 
Single-cell RT-PCR, (379) 1 
Single-chain Fv. (388) 242 
Single-chain Fv fragment, (391) 71 
Single-chain variable fragment, (386) 5 
Single-stranded CAMP response element, (391) 11 
Site A, (397) 169 
Site-directed mutagenesis, (378) 69. 161; (381) 71; (382) 137,171; (384) 
143; (385) 154, 165; (386) 65, 194. 211; (387) 105; (389) 179,268; 
(390) 104.271; (391) 121: (392) 35.91. 121; (394) 87, 361; (395) 17, 
127.225; (397) 183,273: (398) 57, 141,228; (399) 99 
Site-suecific mutagenesis. (379) 161 
Siu gene family. (Y93) 259 
Size difference. (390) 99 
Skeletal ai subunit, (382) 244 
Skeletal muscle. (382) 43; (392) 274; (393) 292; (395) 77; (396) 115 
Skeletal muscle (bullfrog), (380) 267 
Skeletal muscle development. (396) 177 
Skeletal muscle regulaiion. (394) 201 
Skin, (399) 175 
Slow troponin C. (383) 267 
Slow-to-fast transformation. (399) 220 
Small GTPase, (399) 21 I 
Small GTP-binding protein, (385) 221 
Smallpox virus, (382) 79 
Smooth muscle. (391) 45 
Smooth muscle cell. (392) 125, 242; (395) 43 
Snake. (392) 6 
Snake venom, (397) 83 
Snake venom (Bungarus~hsciutus), (387) 196 
SNAP. (393) 185 
SNAP-25, (385) 119, 159 
SNARE. (385) 119; (395) 211 
snoRNA. (379) 212 
Sodium. (399) 3 17 
Sodium channel, (384) 1. 78 
Sodium nitroprusside. (396) 3 15 
Sodium tolerance, (387) 89 
Sodium/proton antiporter. (387) 89 
Sodium-calcium exchange, (394) 99 
Solanaceae, (385) I71 
Solanum b&dens, (383) 159 
Solanum tuberosum, (378) 277: (383) 159 
Soleus muscle, (399) 220 
Solubilization, (391) 199 
Soluble interleukin-6 receptor, (399) 131 
Soluble NSF attachment protein, (394) 83 
Solution hybridization-RNase protection. (394) 279 
Solution structure, (382) 26; (395) 277 
Somatostatin, (397) 164 
Somatostatin receptor. (380) 137 
SOS, (378) 74 
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soxF. (388) 43 
soxL, (388) 43 
Soybean, (381) 203: (391) 238 
Soybean trypsin inhibitor, (396) 108 
$1, (391) 35 
SPI. (399) 14 
SP6 promoter, (382) 327 
Spatial structure. (38 1) I 19 
SP-B, (384) 185 
SP-C, (384) 185 
SPCI) (379) I 13 
Species differences, (389) 219 
Species variability. (389) 249 
Specific r3C labeling, (397) 122 
Specificity, (391) 79 
Specificity conversion, (379) 143 
Specificity determinant, (397) 347 
Spectral change, (391) 134 
Spectrin repeat, (383) 201 
Spectroscopy. (396) 26 
Sperm acrosome reaction, (388) 150 
Sperm maturation, (396) 123 
Spermadhesins (boar), (379) 207 
Spermatocytes. (385) 21 
Spermatogenesis, (385) 21; (388) 150; (396) 293: (397) 250 
Spermatozoa, (391) 263 
Spermidine. (391) 89, I53 
Spermidine/spermine IV]-acetyltransferase, (391) 89 
Spermine. (391) 89 
Sphingolipid activator protein B, (393) 74 
SphinKomonas paucimobili,c. (386) 252 
Sphingomyelin cycle, (394) 237 
Sphingomyelin hydrolysis. (378) 88 
Sphingosine, (379) 177 
Sphingosine-1 -phosphate, (382) 193 
Spinach (Spinacia okracea), (384) 289 
Spinacia oleracerc L., (395) 217 
Spinal cord, (388) 76; (390) 165 
Spindle poison, (392) 237 
Spinaosine l-phosnhate. (379) 260 
Spir&tanol giycoside, (378) I57 
Splice variant. (387) 113; (398) 19; (399) 122 
Splicing, (38 I ) 7 
Sulicing variant, (390) 157 
Sjodopteru Jkgiperda. (389) 238 
Spontaneous transformation. (389) 1 I5 
Spontaneously hypertensive rat. (392) 242 
Sporulation. (378) 98: (381) 29 
SR Ca-ATPase. (379) 286 
src gene. (383) 21 
SRY, (391) 24 
SSCI, (399) 259 
ssi signal, (388) 169 
Stability. (379) 171; (387) 157; (398) 312 
Stabilization, (395) 25 1 
Stable expression. (397) 39 
Stable transfection. (397) 50 
Stable transformation. (380) 257 
Staphylococcal nuclease, (397) 343 
Staphylococcal protein A. (390) 327 
Staphylococcus uurcus. (391) 243 
Staphylococcus c’arnosus. (390) 327 
Staohvlococcus .x~losus. (390) 327 
Staich synthesis,‘(383) 159 
STAT, (396) 77 
STAT protein, (393) 53: (394) 365 
STATl, (386) 239 
Stat2, (381) 191 
STAT3. (386) 239 
STATS, (394) 221 
Staurosporine, (392) 77 
Stem-loop RNA. (386) 60 
Stepwise folding, (391) 167 
Stereochemistry. (389) 12 
Stereospeciticity. (388) 112: (399) 92 
Steroid, (388) 21 
Steroid hormone, (389) 244 
Steroid-induced cataract. (382) 281 
Ster.01 esterification, (392) 161 
Stipule, (379) 117 
Stopped-flow fluorescence. (387) 58 
Store-mediated calcium influx, (38 I) 249 
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